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ABSTRACT

Zhang, Kaidi. Ph.D, Purdue University, May 2015. Expression and Misexpression of the
miR-183 Family in the Developing Hearing Organ of the Chicken. Major Professor:
Donna M. Fekete.

The miR-183 family consists of 3 related microRNAs (miR-183, miR-96 and miR-182)
that are required for the proper maturation of primary sensory cells in both the inner ear
and the retina in mammals. The miR-183 family shows dynamic longitudinal and radial
gradients in the developing mouse cochlea, which raises a question whether the
microRNA levels play a role in specifying hair cell phenotypes. To answer this question,
I used the chicken inner ear to study expression and misexpression of the miR-183 family.
In this study, I reported the differential gene expression of the miR-183 family through
development in the embryonic chicken inner ear by in situ hybridization. The
spatiotemporal expression patterns of all three miRNAs were similar. At E7, labeled hair
cells were present in several vestibular sensory organs. At the same age, expression was
detectable in the apex of the basilar papilla with differentiated hair cells, and a weak
radial gradient was seen with the highest expression on the superior side in the base of the
basilar papillae with undifferentiated precursors. At E12-E18, the higher packing density
of tall hair cells located on the superior basilar papilla suggested the persistence of a
radial gradient from the surface view. However, sections through the basilar papillae
suggested that the miRNA levels appeared to be similar on the superior and inferior sides.
On the other hand, a longitudinal gradient was observed at E16-E18: levels were higher
in the apex than the base. The functional role of the expression gradients in the basilar
papillae was tested by overexpression of the miR-183 family using Tol2 transposasemediated stable expression of the miRNAs. Electroporation of plasmids into the E2-E3

xv
otocyst did not affect hair cell morphologies along the longitudinal axis 11-14 days later,
nor did it affect the differentiation of tall versus short hair cells across the radial axis.
Instead, midway along the longitudinal axis, there appeared to be a higher incidence of
electroporated hair cells relative to supporting cells, indicating a slight bias toward a hair
cell fate. Therefore, the manipulation of the miR-183 family could influence cell lineage
decisions, but it was insufficient to direct the differentiation of hair cells towards specific
radial or longitudinal phenotypes. As a first step toward cataloging potential downstream
genes regulated by members of this hair-cell-enriched miRNA family, I performed
luciferase assays in vitro and verified 14 human gene targets of miR-182.

1

CHAPTER 1. INTRODUCTION

1.1

The chicken inner ear

The chicken ear consists of three segments: outer ear, middle ear and inner ear. The
outer ear is composed of the ear canal and covered by feathers. The middle ear is
separated from the outer ear by the tympanic membrane, also known as eardrum. Instead
of the three bones in the mammalian middle ear, the avian middle ear contains just one,
the columella, which transmits sound vibrations from the tympanic membrane to the oval
window of the inner ear.
The chicken inner ear is divided into vestibular and auditory components
(Bissonnette et al., 1996; Knowlton, 1967). The vestibular periphery for detecting
balance and motion is composed of seven sensory organs, which are anterior crista (AC),
lateral crista (LC), posterior crista (PC), utricular macula (UM), saccular macula (SM),
lagena macula (LM) and macula neglecta. The cristae are located in the ampullae at the
base of the three semicircular canals and are responsible for detecting angular
acceleration. Otoconia composed of calcium carbonate crystals are suspended above the
maculae that play a role in linear acceleration and gravity detection. The auditory organ,
called the basilar papilla (BP), is located on the basilar membrane and covered by
tectorial membrane in the cochlear duct (Tanaka et al., 1978). The lateral surface of the
cochlear duct is composed of the tegmentum vasculosum (Cotanche et al., 1982). Similar
to the stria vascularis in the mammalian cochlea, the function of tegmentum vasculosum
is to make the endolymphatic fluid with a high concentration of potassium in the cochlear
duct.
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The functional units of all eight sensory organs have three conserved elements:
sensory hair cells (HCs), supporting cells (SCs) and peripheral ends of sensory neurons.
HCs transmit mechanical vibrations from sounds or movements into electric signals,
known as mechanotransduction. Displacement of the stereocilia on the apical surface of
HCs results in mechanotransduction channel opening, membrane potential depolarization
and release of neurotransmitter. SCs are located underneath the HC layer. Their function
is not only to provide mechanical support for HCs, but also to release trophic and survival
factors and to regenerate HCs after damage. The primary afferent neurons synapse at the
base of the HCs and transmit information to the central nervous system. The central
axons of the auditory and vestibular neurons both belong to the eighth cranial nerve.
1.1.1

Longitudinal axis along the basilar papilla

As in the mammalian cochlea, HCs along the BP exhibit different sensitivities to
specific frequencies depending on their positions in a phenomenon called tonotopy
(reviewed in (Mann et al., 2011)). HCs located at the base of the BP (or the proximal end)
are responsible for the detection of high frequency sounds at ~5000 Hz, while HCs at the
apex (or the distal end) detect low frequency sounds at ~50 Hz. The HCs at the base and
at the apex show both morphological and physiological differences from as early as E12
(Fuchs et al., 1988; Tilney et al., 1992). HCs located at the distal end have around 50
stereocilia with the longest stereocilia of 5.5µm in length; HCs at the proximal end have
300 stereocilia, of which the maximum length is 1.5µm (Tilney et al., 1983; Tilney et al.,
1992). The lumenal surface areas of HCs change progressively along the longitudinal
axis, with HCs with smaller surface areas located more distally (Figure 1-1). At the same
time, the HC density increases progressively from the proximal end to the distal end. In
addition, HC and SC patterning varies both along the longitudinal and radial axes
(Goodyear et al., 1997). Average SC to HC ratio is 1.71 at the apex in E12 BPs, while the
ratios at the neural and abneural sides of the base are 2.14 and 3.90 respectively.
Based on electrophysiological data, the characteristic frequency of HCs depends
mainly on the gating kinetics of large conductance calcium-activated potassium channels
(BK channel) encoded by the slo gene. HCs at the low frequency region have slowly-
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gated BK channels, whereas HCs tuned to higher frequencies have more rapidly-gated
channels (Duncan et al., 2003; Ricci et al., 2003). The kinetic variation of BK channels
can arise from alternative splicing of slo transcripts encoding pore-forming α subunits in
combination with accessary β subunits (Fettiplace et al., 1999). The combination with β
subunits, which are preferentially expressed in low-frequency HCs at the apex, slows the
gating kinetics of BK channels (Ramanathan et al., 2002; Ramanathan et al., 1999).
At the molecular level, gene expression studies done in chicken BP at E6.5, E14, P0
and P14-16 have recognized thousands of genes with different expression levels between
the apex and base (Frucht et al., 2011; Kowalik et al., 2011; Mann et al., 2014; Thiede et
al., 2014). The differentially expressed transcripts at P14-P16 include three groups of
gene products according to gene ontology analysis, which are (1) synaptic transmission
and neurotransmitter secretion, (2) gated channel activity and ion transport, and (3)
developmental process and cell proliferation (Kowalik et al., 2011).
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Figure 1-1 Schematic of the basilar papilla
Along the longitudinal axis of the BP, HCs at the base detect high frequency sounds with
big cell surface area and short stereocilia bundles, while HCs at the apex have long cell
bodies and long stereocilia bundles and respond best to low frequency sounds. Across the
radial axis of the BP, THCs reside on the neural/superior side and SHCs are located on
the abneural/inferior side. Modified from Tanaka & Smith, 1978 (Tanaka et al., 1978).
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The identity of positional signals underlying the tonotopy of the BP was not
determined until recently (Mann et al., 2014; Thiede et al., 2014). The experiment of
separating BPs at different time points into proximal and distal halves and culturing the
explants in vitro suggests that the tonotopic identity along the BP is established before E7
and potential positional signals are expressed at the apex (Mann et al., 2014). Microarray
and RNA-seq data from E6.5 BPs show that members of bone morphogenetic protein
(BMP) signaling pathway are differentially expressed between the base and the apex,
such as BMP7 with higher expression at the apex and BMP antagonists with higher
expression at the base. Treatment with BMP7 in the media or by soaked beads in vitro
and overexpression of BMP7 in vivo both show evidence that BMP7 induces a more
distal phenotype in the proximal end of the BP, while inhibition of BMP7 signaling by
Chrdl1 (chordin-like 1) or Noggin induces a proximal phenotype (Mann et al., 2014). The
signaling pathway of BMP7 in tonotopy regulation is a non-canonical pathway via
activating Tak1/Map-kinase. Another study indicates that retinoic acid (RA) signaling is
also involved in the tonotopic patterning of the BP (Thiede et al., 2014). At E10, Raldh3
(aldehyde dehydrogenase 1 family, member A3), one RA synthesizing enzyme, is
expressed with a distal-to-proximal gradient, resulting in high level of soluble RA in the
distal BP. In vitro culture experiments suggest that RA signaling is necessary and
sufficient to promote apical HC phenotypes. RA signaling is involved in the specification
of length and number of HC bundles by promoting the expression of two actin crosslinker genes, Espin and Fscn2. Taken together, BMP7 and RA signalings are both
involved in patterning the longitudinal gradients of HC features along the BP.
However, the cues establishing the initial positional identity and underlying the
longitudinal expression of BMP7 and Raldh3 have not been discovered. The cues could
be exogenous from the neural tube or notochord, or could originate from the dorsal
vestibular apparatus.
1.1.2

Radial axis across the basilar papilla

A separate functional dichotomy is present across cochlear duct in the orthogonal
dimension, called the radial axis. In the mammalian cochlea, the radial axis is notable for
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its distribution of two major HC types, one row of inner HCs (IHCs) and three rows of
outer HCs (OHCs), located on either side of the tunnel of Corti. The function of IHCs is
to transduce mechanical sounds into electrical information for auditory sensation. OHCs
are responsible for cochlear amplification via prestin-mediated electromotility (Liberman
et al., 2002). IHCs on the medial side of the tunnel of Corti are flask-shaped and have Cshaped stereocilia on their apical surfaces, while cylindrical-shaped OHCs on the lateral
side have W-shaped stereocilia (Lim, 1986). Furthermore, the highest rows of stereocilia
bundles of OHCs are touching the tectorial membrane, whereas bundles of IHCs are not
touching the tectorial membrane, but rather loosely coupled. IHCs and OHCs also have
different innervation patterns (Bulankina et al., 2012; Rubel et al., 2002). 92-95% of the
afferent fibers from the spiral ganglion (SG) are type I myelinated afferent fibers that
innervate IHCs, whereas the rest are type II non-myelinated afferent fibers reaching
OHCs (Romand et al., 1990). On the other hand, efferent fibers from neurons dispersed
around the medial olivocochlear nucleus directly innervate OHCs, while fibers from
neurons surrounding the lateral olivocochlear nucleus terminate on type I afferents that
innervate the IHCs.
Likewise, two distinct populations of HCs are recognized as tall HCs (THCs) on the
superior (neural) half of the organ and short HCs (SHCs) on the inferior (abneural) half in
the avian BP (Tanaka et al., 1978). But, rather than presenting an abrupt change from one
type into the other, as is observed for the mammalian cochlea, in the bird BP the
transition from THCs to SHCs is gradual across the radial axis, with cells between them
displaying intermediate morphological features. Like IHCs, THCs are predominantly
innervated by afferents, while SHCs are innervated mainly by efferent nerve fibers
(Fischer, 1992). Through active hair bundle motion caused by mechanotransducer
channel gating and an electromechanical force generator akin to prestin, SHCs generate
sufficient force to displace tectorial membrane laterally, which can be transmitted to
THCs not overlying the basilar membrane (Beurg et al., 2013).
The mechanisms specifying the different cell fates across the radial axis in both the
avian and mammalian cochleae remain an active area of investigation.
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1.2

Inner ear development

The endolymphatic compartment of the inner ear derives from the otic placode,
which is visible as a thickening ectoderm adjacent to the hindbrain at E2/S10 in the chick.
The otic placode further invaginates to form the otic cup. The otic cup closes to form the
otic vesicle or otocyst at E3/S17 in the chick. The progenitor cells in the otocyst will
generate three inter-related lineages of prosensory (become HCs and SCs in sensory
organs), proneural (become auditory and vestibular neurons in the cochleovestibular
ganglion, CVG) and non-sensory cells. Proneural cells delaminate from the anteroventral
region of the otic cup and later form the CVG. By E4/S24, all prosensory domains are
expressing specific markers except the macula neglecta; by E7/S31, nascent HCs can be
observed in all sensory patches. During sensory organ specification and differentiation,
the expression patterns of BMP4 and other sensory markers demonstrate that AC and PC
are the sensory organs that arise first at S19, followed by SM at S20, LC at S22, BP and
LM at S23, UM at S24 and the macula neglecta at S29 (Wu et al., 1996).
The preplacodal region that gives rise to the otic placode and the epibranchial
placodes is also known as otic-epibranchial progenitor domain. Epibranchial placodes
(Begbie et al., 1999) will develop into the geniculate, petrosal and nodose ganglia.
Overexpression and inhibition studies in the chicken suggest that the interplay of
fibroblast growth factor (FGF) and Wnt signaling is involved in the induction of the otic
and epibranchial placodes (Freter et al., 2008). The initial induction of otic-epibranchial
progenitor domain needs FGF signaling by S5. Subsequently, the commitment of oticepibranchial progenitor domain to otic placode after S7 results from canonical Wnt
signaling and attenuation of FGF signaling. Conversely, the continued FGF signaling
leads to the epibranchial placode differentiation, which is inhibited by canonical Wnt
signaling.
1.2.1

Axial specification

After induction of the otic placode, extrinsic signals from the surrounding tissues
lead the otic placode to acquire positional identities along its anterior-posterior, dorsalventral, and medial-lateral axes (Groves et al., 2012; Raft et al., 2014; Wu et al., 2012).
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Recent findings using the chick-quail grafting model demonstrated that the avian otic
placode at S10 is composed of three dorsoventrally-arranged anteroposterior domains
(Sánchez-Guardado et al., 2014). The dorsal-most domain generates endolymphatic sac
and duct. The intermediate domain develops and forms the maculae, the BP and their
surrounding non-sensory epithelia. The ventral-most domain gives rise to the ampullary
cristae and the semicircular canals (Sánchez-Guardado et al., 2014). This fate map
coincides with the results obtained from an earlier study that injected lipophilic dye into
different sites around the rim of the otic cup (Brigande et al., 2000). The entire dorsal rim
of the otic cup displaces medially and becomes the endolymphatic duct. The
posteroventral rim becomes the lateral wall of the otocyst, which will give rise to the
vertical and horizontal canal pouches.
Embryonic manipulation of the developing inner ear in chicken embryos reveals that
the anterior-posterior axis for the sensory organs is determined before the dorsal-ventral
axis (Wu et al., 1998). The anterior-posterior position and identity of the sensory organs
are already fixed at the time of transplantation at S16-17/E2.5, whereas the dorsal-ventral
axis is not fixed and can be re-specified. This suggests that sensory organ formation may
require multiple steps and different extrinsic signals. The anterior region of the otic cup
with regionalized expression of Lfng, Fgf10 and Sox2, known as neurosensory-competent
domain (NSD), gives rise to neurons and most sensory organs in the inner ear. Bok and
colleagues found that RA is involved in the establishment of the anterior-posterior axis in
the otic cup in both the mouse and the chicken and low levels of RA are required for
anterior NSD formation (Bok et al., 2011). At S8-S13 in the chicken, the RA synthetic
enzyme Raldh2 is expressed in the mesodermal tissues posterior to the otic cup, while the
RA degradation enzyme Cyp26 is expressed in the ectoderm anterior to the otic cup,
which together generates high RA level towards the posterior otic region. Implantation of
a RA-soaked bead in mesoderm anterior to the otic cup in chicken results in
downregulation of Lfng and the otic cup develops into a symmetrical inner ear with only
two cristae and their associated posterior-like canals (Bok et al., 2011).
The establishment of dorsal-ventral axis of the otic cup involves canonical Wnt/βcatenin signaling from the dorsal hindbrain and sonic hedgehog (Shh) signaling from the
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ventral floor plate and notochord (Bok et al., 2005; Riccomagno et al., 2005).
Dorsoventral inversion of the hindbrain and notochord leads to ventral gene expression in
the dorsal otocyst and removal of the Shh source by ablating ventral midline structure
(floor plate and/or notochord) results in the loss of ventral inner ear structures in the
chicken (Bok et al., 2005). Shh signaling plays an important role in the acquisition of
ventral identities, whereas Wnt signaling is involved in the acquisition of dorsal identities.
Overexpression of an activated format of β-catenin or chicken Wnt3a by retrovirusmediated gene transfer results in ectopic vestibular sensory patches in the ventral
cochlear duct in the chicken (Stevens et al., 2003). There is more evidence that supports
the involvement of Wnt signaling in dorsal-ventral patterning from mouse studies
(Riccomagno et al., 2005). Forced activation of the Wnt/β-catenin pathway by lithium
chloride in otic explants is sufficient to induce ventral expansion of some dorsal markers.
Wnt1-/-; Wnt3a-/- double mutant mice have no expression of otic dorsal markers and no
vestibular development. However, the dorsal-ventral patterning is more complicated than
a simple model of Shh and Wnt opposing gradients (Groves et al., 2012). At present, it is
unclear what is the mechanism independent of Shh and Wnt contributing to establishing
the dorsal-ventral axis of the inner ear.
1.2.2

Sox2 in inner ear development

Progenitor cells in the NSD of the otic placode will generate neurons and sensory
cells. Lineage analysis in the chicken ear using replication-defective retroviruses
demonstrates that the neurons in the CVG and sensory cells in the UM can share a
common progenitor in the NSD (Satoh et al., 2005). Fate mapping studies of Wnt
signaling in the mouse inner ear reveal that Wnt responsive cells in the dorsomedial otic
cup at E8.5 are the earliest known origins of the NSD and they have a dorsal-to-ventral
movement, contributing to both the vestibular and auditory apparatus (Brown et al.,
2015).
The NSD can be identified by the expression of Sox2, Sox3, Fgf10 and Lfng (Abelló
et al., 2007; Neves et al., 2007). Sox2 and Sox3 are members of SoxB1 subgroup and are
High Mobility Group box domain transcriptional activators (Uchikawa et al., 1999). Sox2
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is expressed in the neurogenic and prosensory domains in the developing otocyst and
then becomes downregulated in differentiating neurons and HCs, but continues to be
expressed in SCs (Neves et al., 2007). The initial expression of Sox2 in the NSD depends
on FGF signaling and Sox3 (Abello et al., 2010).
Evidence in mouse and chick reveals that Sox2 is both necessary and sufficient for
neuronal and HC development in the inner ear (Kiernan et al., 2005b; Neves et al., 2011;
Puligilla et al., 2010). Sox2 cooperates with transcription factors Eya1 and Six1 to bind to
the conserved Sox- and Six-binding sites in Atoh1 enhancers, thereby activating Atoh1
transcription to induce a HC fate (Figure 1-2) (Ahmed et al., 2012b). For neuronal
differentiation, Sox2 interacts with the SWI/SNF chromatin-remodeling subunits in
addition to Eya1 and Six1 to activate the transcription of Neurog1 and the downstream
gene Neurod1 (Ahmed et al., 2012a). Absence of Sox2 expression in Lcc mouse mutants
results in complete loss of prosensory domains and auditory ganglion neurons (Kiernan et
al., 2005b; Puligilla et al., 2010). Ectopic expression of Sox2 by electroporation into
chicken otic vesicles at E2 induces ectopic sensory and neurogenic patches (Neves et al.,
2011). However, gain-of-function studies of Sox2 have yielded inconsistent results in the
size of CVGs. Neves and colleagues show increased volume of CVGs (Neves et al.,
2011), while another study shows the formation of smaller CVGs after electroporation of
Sox2 at E1.5 (Evsen et al., 2013).
The downregulation of Sox2 in neurons and HCs are shown to be necessary for their
further differentiation (Dabdoub et al., 2008; Evsen et al., 2013). Misexpression of Sox2
in the developing chicken inner ear inhibits the progression of neurogenesis (Evsen et al.,
2013). Forced expression of Sox2 in mouse cochlear explants prevents the prosensory
cells from developing as HCs after 6 days in vitro (Dabdoub et al., 2008). Atoh1 in HCs
and Neurog1 and Neurod1 in neurons are involved in the down-regulation of Sox2. There
is evidence that expression of Atoh1 results in down-regulation of Sox2 in embryonic
carcinoma cells (Dabdoub et al., 2008). Neurog1 and Neurod1 inhibit Sox2 transcription
by binding to a conserved Sox2 enhancer to promote neuronal differentiation (Evsen et al.,
2013). Taken together, Sox2 plays two important roles during HC and neuronal
development: (1) it leads the progenitors to acquire a sensory or neuronal fate by up-
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regulating Atoh1 and Neurog1 respectively; (2) it prevents further differentiation of the
progenitors until Atoh1 and Neurog1 feed back to inhibit Sox2 expression (Raft et al.,
2014). Neves and colleagues proposed an incoherent feed-forward loop model to explain
the dual function of Sox2 (Neves et al., 2013a): on one hand Sox2 activates Atoh1 and
Neurog1, while on the other hand it stimulates the expression of other basic Helix-LoopHelix (bHLH) transcription factors that inhibit the expression and/or function of Atoh1
and Neurog1 (Figure 1-2). The candidates of the repressors include Id family and Hes
and Hey families.
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Figure 1-2 Regulation of Atoh1 and Neurog1 by Sox2
The diagram depicts the incoherent feed-forward loop of Atoh1 and Neurog1 regulation
by Sox2. Sox2 activates the expression of Atoh1 and Neurog1, but also activates other
bHLH transcriptional inhibitors to inhibit their expression, for example Hes, Hey or Id.
Atoh1 and Neurog1 both inhibit Sox2 expression and they also inhibit each other to
promote HC fate or neuronal fate respectively. Of note, Atoh1 can recognize its own
enhancer, resulting in autoregulation.
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1.2.3

Neurog1 in neurogenesis

Neurogenesis in the inner ear starts as early as the otic cup stage (Adam et al., 1998).
The bHLH transcription factor Neurog1 is expressed in neuronal precursors before their
delamination and is recognized as a vertebrate neuronal determination gene, because it is
necessary and sufficient in the acquisition of a neuronal fate (Ma et al., 1998). Neurog1
null mouse mutants lose the entire CVG (Ma et al., 1998) and also have smaller sensory
epithelia (SE), in particular, the saccule of reduced size with few HCs due to earlier HC
cycle exit (Ma et al., 2000; Matei et al., 2005). Ectopic expression of Neurog1 induces
the neuronal phenotype in non-sensory cells within the cochlea (Puligilla et al., 2010).
Neurog1 can be identified as a proneural gene in the inner ear, because it is first
expressed broadly and then become restricted. Tracing the lineage of Neurog1-expressing
cells with tamoxifen-inducible Neurog1CreER transgenic mice reveals that the Neurog1
domain at E8.5-9.5 can give rise to neurons, HCs and SCs of the maculae, and nonsensory cells and then contracts gradually in the primordia of the utricle and saccule from
E8.5 to E13.5 (Raft et al., 2007).
Neurog1 promotes the expression of another closed related bHLH gene, Neurod1,
which is also necessary and sufficient for the differentiation and survival of CVG neurons
(Kim et al., 2001; Puligilla et al., 2010). Delaminated neuroblasts proliferate to form the
CVG (Adam et al., 1998) and then differentiate into vestibular and auditory neurons
innervating HCs in the corresponding sensory organs.
1.2.4

Atoh1 in hair cell development

After neurogenesis, the NSD is patterned into distinct prosensory patches composed
of common progenitors that will give rise to HCs and SCs (Fekete et al., 1998). The bestcharacterized gene that is associated with HC fate determination is another bHLH
transcription factor Atoh1 (Bermingham et al., 1999). Atoh1 expression in the mouse
cochlea is first observed at the mid-basal turn around E13.5 and extends to the full length
of the cochlear duct by E15 as cochlea grows (Chen et al., 2002; Lanford et al., 2000). By
P3, Atoh1 expression begins to decrease, which also follows a basal-to-apical gradient.
Studies done in Atoh1EGFP or Atoh1A1GFP knock-in mice demonstrate that Atoh1 is first
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expressed in a subset of post-mitotic precursors within the cochlear sensory primordium,
before the differentiation of HCs and then becomes restricted to differentiating HCs (Cai
et al., 2013; Chen et al., 2002). Lineage analysis of Atoh1-expressing cells is performed
using Atoh1Cre or Atoh1CrePR knock-in mice crossed with Cre reporter lines (Driver et al.,
2013; Yang et al., 2010). In both the vestibular and auditory sensory organs, SCs that
derive from Atoh1-expressing cells are observed. Cai and colleagues interpret (Cai et al.,
2014) that Atoh1 starts to be expressed in HC precursors immediately before their
commitment to a HC fate, but some of the precursors can be diverted to a SC fate,
probably due to Notch-mediated lateral inhibition.
Atoh1 is important for HC survival and development. HCs are completely absent in
Atoh1 null mice (Bermingham et al., 1999). Due to the absence of Atoh1, the precursors
cannot start HC differentiation, but undergo apoptosis, which starts at the base and then
spreads to the apex, similar to the normal HC differentiation pattern (Chen et al., 2002).
Transient expression of Atoh1 in Atoh1 conditional knockout (CKO) mice in which Cre
expression is driven by an Atoh1 autoregulatory enhancer results in loss of most HCs and
abnormal stereocilia bundles in the remaining HCs (Pan et al., 2012). Studies in Atoh1
CKO mice that delete Atoh1 at different time points (Cai et al., 2013) indicate that there
is a critical 2-day time window when Atoh1 is absolutely required for HC survival.
Knockout of Atoh1 within 2 days after the initiation of Atoh1 expression leads to HC loss
followed by the loss of surrounding SCs. Deletion of Atoh1 at later time points does not
cause immediate HC loss, but leads to disorganized hair bundles, delayed HC death and
damaged auditory function.
Atoh1 is also sufficient for HC differentiation (Gubbels et al., 2008; Liu et al., 2014;
Liu et al., 2012b; Yang et al., 2012; Zheng et al., 2000a) and non-autonomous SC
production (Kelly et al., 2012; Woods et al., 2004). Due to the fact that mammalian HCs
cannot regenerate after damage, lots of studies have been done to figure out the role of
Atoh1 in HC regeneration. However, the competency of HC induction by Atoh1
misexpression is progressively decreased in postnatal mice up to the age of hearing onset
(Kelly et al., 2012; Liu et al., 2012b).

15
1.2.5

Notch-mediated lateral induction and inhibition

Notch signaling plays important and diverse roles in inner ear development,
including but not limited to lateral induction in prosensory patterning and lateral
inhibition in neurogenesis and HC differentiation (Kiernan, 2013; Neves et al., 2013b)
(Figure 1-3). Notch signaling in trans is trigged by the interaction between
transmembrane Notch receptors in one cell and transmembrane Notch ligands (DSL
family, Delta-like and Jagged in mammals, Delta and Serrate in Drosophila melanogaster,
Lag-2 in Caenorhabditis elegans) in its neighboring cells. There are two known Notch
receptors (Notch1 and Notch2) and four Notch ligands (Serrate1 and 2 and Delta-like-1
and 4) in birds. The binding between Notch receptors and ligands leads to the release of
Notch intracellular domain (NICD) by γ-secretase proteolytic activity. NICD is the active
form of Notch and will be translocated to the nucleus and interact with the CSL
transcriptional factor (also known as RBPj). In the absence of NICD, CSL recruits corepressors and represses the transcription of target genes. In the presence of NICD, CSL
displaces co-repressors, binds with co-activators such as MAM and activates the
transcription. The best-characterized target genes are the Hes and Hey genes, which
encode bHLH transcription repressors. In chicken inner ear, Notch1 is expressed widely
from S11/E1.5 in otic placode to at least E12 in both sensory and non-sensory regions
(Abelló et al., 2007; Adam et al., 1998).
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Figure 1-3 Notch-mediated lateral induction and inhibition
Lateral induction is involved in the patterning of sensory progenitors in the inner ear.
Serrate1-expressing cell activates Notch signaling and promotes Serrate1 expression in
its neighboring cells, which generates a positive feedback loop between Notch and its
ligand Serrate1. Lateral inhibition is characterized by a negative feedback loop by which
Delta1 or Serrate2 activates Notch signaling and then suppresses the expression of Delta1
or Serrate2 in its neighboring cells. As a result, the ligand-delivering sensory precursor
has inactive Notch activity and differentiates into a HC, whereas the surrounding cells
with high Notch activity adopt a SC fate.
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Notch-mediated lateral induction involves a positive feedback loop in which a cell
expressing Notch ligands activates Notch signaling and promotes ligand expression in its
neighboring cells (Figure 1-3). The result is that all the cells in the patch will adopt the
same cell fate. Lateral induction in prosensory patterning in the inner ear involves
Serrate1/Jagged1 (Serrate1 in chicken and Jagged1 in mouse) as a Notch ligand. Serrate1
is expressed early in the otic placode at S11 and in all the prosensory domains at S26/E5
(Adam et al., 1998). Both loss-of-function and gain-of-function studies of Notch
signaling indicate that Serrate1 expression is positively regulated by Notch signaling,
which is consistent with the positive feedback loop in lateral induction (Daudet et al.,
2005; Daudet et al., 2007). Jagged1 CKO mutant mice show down-regulation of Sox2
and have no cristae formed, a smaller utricle and a truncated cochlea (Brooker et al., 2006;
Kiernan et al., 2006). Gain-of-function studies of Serrate1 in the chick inner ear show
that ectopic Serrate1 expression can induce the expression of Sox2 or HC formation only
within the NSD with early Sox2 expression, but not outside the NSD, suggesting that
Jagged1-mediated Notch signaling maintains, rather than initiates the formation of
prosensory patches (Daudet et al., 2007; Neves et al., 2011).
Lateral inhibition involves a negative feedback loop in which a cell expressing
Notch ligands signals to its neighbors to suppress ligand expression (Figure 1-3). Thus,
the Notch signaling is inactivated in the ligand-expressing cell which will differentiate
into one cell fate, whereas the surrounding cells with high levels of Notch activity will
differentiate into an alternative cell fate. The adoption of the two different cell fates is
accompanied by salt-and-pepper gene expression patterns. Lateral inhibition in inner ear
development is involved in both neurogenesis and HC determination. Delta1 is expressed
in otic neuron precursors before their differentiation (Adam et al., 1998). Dll1 (Deltalike-1) CKO mice have an increased CVG at the expense of SM and UM, which indicates
that absence of Dll1-mediated lateral inhibition causes prosensory cells of the maculae to
adopt a neuronal fate (Brooker et al., 2006). Treatment with DAPT, a γ-secretase
inhibitor, leads to blockage of Notch signaling, expansion of Dll1 expression and
increased number of neuroblasts in the chicken inner ear in vitro (Abelló et al., 2007;
Daudet et al., 2007).
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Lateral inhibition in HC and SC fate determinations requires two Notch ligands,
Dll1 and Serrate2/Jagged2 (Serrate2 in chicken and Jagged2 in mouse). Dll1 expression
is restricted to a subset of the progenitor cells in the sensory patches and foreshadows HC
differentiation in chick (Adam et al., 1998). In mouse inner ear, Dll1 and Jagged2 are
both expressed in nascent HCs (Lanford et al., 1999; Morrison et al., 1999). Conditional
inactivation of the two ligands in mice leads to supernumerary HCs at the expense of SCs
(Kiernan et al., 2005a). Misexpression of Dll1 in the chicken inner ear promotes the
formation of HC cell-autonomously and inhibits their neighbors from adopting a HC fate
(Chrysostomou et al., 2012). Forced activation of Notch signaling by overexpressing
NICD in chick otocyst results in inhibition of HC differentiation within sensory patches
(Daudet et al., 2005). The direct targets of Notch activation in sensory precursors include
Hes and Hey (Petrovic et al., 2014). Hes and Hey are known to counteract Atoh1 by
inhibiting HC formation and promoting SC fate (Li et al., 2008; Tateya et al., 2011;
Zheng et al., 2000b; Zine et al., 2001).
1.3

microRNAs

Small silencing ribonucleic acids (RNAs) are defined as RNAs with the length of
about 20-30 nucleotides and an association with Argonaute (AGO) family of proteins that
serves to suppress expression of target genes or unwanted genetic materials (Ghildiyal et
al., 2009). Small silencing RNAs in animals are classified into three classes: microRNAs
(miRNAs), small interfering RNAs (siRNAs) and PIWI-interacting RNAs (piRNAs).
siRNAs typically derive from long double-stranded RNA (dsRNA) precursors processed
by Dicer, which can be further categorized into endo-siRNAs and exo-siRNAs (the latter
from exogenous sources). piRNAs are the longest small RNAs with 24-30 nucleotides
and their maturation is Dicer-independent. They bind with the PIWI clade of AGO
proteins to silence transposons in germline development.
miRNAs are about 22 nucleotides long and are produced from single-stranded
RNAs by two ribonuclease III enzymes, Drosha (animals only) and Dicer. miRNAs
recognize mRNA targets by Watson-Crick base-pairing and guide AGO proteins to
mRNAs. AGO proteins function as effectors by recruiting silencing factors, leading to
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translational repression and mRNA decay (Huntzinger et al., 2011). The repression in
protein production is modest and rarely exceeds fourfold reduction (Baek et al., 2008;
Selbach et al., 2008). Despite the general assumption of miRNA-mediated RNA silencing,
there is evidence supporting the view that miRNA can upregulate gene expression
directly or indirectly in specific conditions (Valinezhad Orang et al., 2014; Vasudevan et
al., 2007). The binding sites of miRNAs in animals are generally located in the 3’
untranslated region (3’UTR) of mRNAs (Bartel, 2009; Gu et al., 2009). The vast majority
of miRNAs are partially complementary to their mRNA targets. The target recognition of
miRNAs depends mainly on perfect base-pairing of the nucleotides 2-7 at the 5’end of
the miRNAs, known as “seed region”. Additional pairing of miRNA nucleotide 8 and
nucleotides 13-16 and adenine across from the first nucleotide of the miRNA can
enhance seed binding (Bartel, 2009).
The current miRNA database, miRBase 21, has 28645 miRNA loci, which
includes 1881 annotated human miRNA loci encoding 2558 mature miRNAs (GriffithsJones et al., 2008; Griffiths-Jones et al., 2006; Kozomara et al., 2011; Kozomara et al.,
2014). About 60% of protein-coding genes in human contain at least one conserved
miRNA-binding site under selective pressure during evolution and the targeted 3’UTRs
have an average of 4.2 miRNA-binding sites (Friedman et al., 2009b). Considering the
presence of non-conserved target sites, it is not surprising that miRNAs affect almost all
cellular pathways, from development to oncogenesis (Bushati et al., 2007; EsquelaKerscher et al., 2006; Kloosterman et al., 2006a; Lujambio et al., 2012).
1.3.1

microRNA biogenesis

In the canonical miRNA biogenesis pathway (Figure 1-4), RNA polymerase II
transcribes miRNA genes into long primary miRNAs (pri-miRNAs), mainly from introns
of non-coding or coding transcripts in animals (intronic miRNAs) (Lee et al., 2004;
Rodriguez et al., 2004). Some miRNAs are encoded by exons of non-coding transcripts
(exonic or intergenic miRNAs). The pri-miRNAs contain stem-loop structures where
mature miRNA sequences are embedded, begin with a 7-methylguanosine cap and end
with a 3’ poly(A) tail. The expression of intronic miRNAs usually coincides with the
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transcription of their host genes, indicating that they may be generated from a common
precursor transcript (Baskerville et al., 2005; Rodriguez et al., 2004). Recent studies
reveal that about 35% of intronic miRNAs have predicted upstream promoters distinct
from the host gene promoters, suggesting that the expression of these miRNAs can occur
independent of the host gene transcription (Monteys et al., 2010). Some miRNA loci are
located in close conjunction in the genome and thereby can be processed by a
polycistronic transcription unit (Lee et al., 2002). Nonetheless, the expression of
individual miRNAs can be regulated at a post-transcriptional level, leading to different
levels among miRNAs from one polycistronic transcription unit. For instance, the
expression of let-7 miRNA from the cluster of miR-100, let-7 and miR-125 can be
suppressed post-transcriptionally by LIN28 (Roush et al., 2008).
Following transcription, pri-miRNAs are cleaved into a stem-loop structure of about
60 nucleotides, precursor miRNAs (pre-miRNAs), by the microprocessor complex in the
nucleus. The microprocessor complex is comprised of the ribonuclease III Drosha and the
dsRNA-binding protein DGCR8 (DiGeorge syndrome critical region 8, DGCR8 in
mammals and Pasha in other animals) (Gregory et al., 2004; Han et al., 2004; Han et al.,
2006). The cleavage of Drosha defines the terminus of miRNAs embedded in the premiRNAs. The current model is that the Drosha-DGCR8 complex measures ~22
nucleotides from the apical stem-loop junction and ~11 nucleotides from the basal stemsingle-stranded RNA junction to determine the cleavage site (Han et al., 2006; Ma et al.,
2013). Drosha cleavage creates a two-nucleotide-long 3’ overhang in the pre-mRNAs.
Studies on processing of intronic miRNAs indicate that pre-miRNAs are cleaved cotranscriptionally before host intron splicing (Kataoka et al., 2009; Kim et al., 2007;
Morlando et al., 2008). Furthermore, the cleavage of the intron by Drosha does not affect
the processing of the host mRNA, thereby ensuring both miRNA and protein production
from a single primary transcript.
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Figure 1-4 microRNA biogenesis and gene silencing
The cartoon depicts the biogenesis of miRNAs and miRNA-mediated RNA silencing. primiRNA is transcribed from intronic or exonic miRNA gene by RNA polymerase II. The
mature miRNA sequence is embedded in the stem-loop structure in the pri-miRNA. The
microprocessor complex composed of Drosha and DGCR8 cleaves pri-miRNA into premiRNA of about 60 nucleotides. Exportin 5 will transport pre-miRNA from the nucleus
to the cytoplasm where Dicer will cleave pre-miRNA into a miRNA duplex of about 22
nucleotides. The miRNA duplex is loaded into AGO, which is called pre-RISC. The
miRNA duplex will be unwound so that only mature miRNA stays inside the mature
RISC. The presence of the miRNA then guides RISC to its target mRNA, primarily
determined by base paring between the miRNA seed region and the mRNA 3’UTR. The
result is mRNA decay induced by deadenylation and decapping or translation repression.
m7G: 7-methylguanosine cap; ORF: open reading frame.
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After Drosha cleavage, pre-miRNA is exported into the cytoplasm by nuclear
transport protein exportin 5 (EXP5, Ranbp1 in flies) (Bohnsack et al., 2004; Lund et al.,
2004; Yi et al., 2003). EXP5 requires the association of RanGTP to mediate nuclear
export of pre-miRNAs and GTP will be hydrolyzed during the translocation.
In the cytoplasm, another ribonuclease III enzyme Dicer (Dicer-1 in flies) cleaves
pre-miRNAs into ~22 nucleotide miRNA duplex (Bernstein et al., 2001; Grishok et al.,
2001; Hutvágner et al., 2001). Dicer in mammals determines the cleavage sites by
measuring ~22 nucleotides away from both 5’ and 3’ ends of pre-miRNAs (Park et al.,
2011; Vermeulen et al., 2005). Similar to Drosha, Dicer interacts with two dsRNAbinding proteins in mammals, TRBP (transactivation-response RNA-binding protein,
Loqs in flies) and PACT (protein kinase R-activating protein) (Chendrimada et al., 2005;
Lee et al., 2013; Lee et al., 2006). TRBP can alter the cleavage site of Dicer within the
pre-miRNA and thereby tune the length of mature miRNAs (Fukunaga et al., 2012; Lee
et al., 2012).
Upon Dicer cleavage, the miRNA duplex is loaded onto an AGO protein and forms
a RNA-induced silencing complex (RISC). The assembly of RISC needs at least two
steps: RISC loading and strand dissociation or unwinding of miRNA duplex (Kawamata
et al., 2010). There are three classes of AGO proteins: AGO superfamily associated with
miRNAs and siRNAs, PIWI superfamily associated with piRNAs and worm-specific
WAGO clade (Hutvagner et al., 2008). The PIWI domain in AGO proteins has splicer
activity to cleave mRNA transcripts between nucleotide positions 10 and 11 from
miRNA 5’ end (Parker et al., 2005; Song et al., 2004). However, only AGO2 among
mammalian AGO1-4 has endonucleolytic activity to cleave highly complementary
mRNA targets (Liu et al., 2004). In Drosophila melanogaster, miRNA duplexes with
mismatches in the central region are generally loaded into AGO1 for RISC assembly,
whereas siRNA duplexes with high complementarity are sorted into AGO2 by Dicer-2
and its dsRNA-binding protein partner R2D2 (known as RISC-loading complex)
(Förstemann et al., 2007; Liu et al., 2003; Tomari et al., 2007). Nonetheless, there is no
evidence for strict small RNA sorting among the four AGO proteins in mammals
(Azuma-Mukai et al., 2008; Dueck et al., 2012; Su et al., 2009; Yoda et al., 2010). The
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libraries of miRNAs associated with AGO2 and AGO3 overlap to a large extent (AzumaMukai et al., 2008).
After the loading of miRNA duplex into AGO, the passenger strand (also known as
miRNA*) of miRNA duplex is dissociated from the guide strand and removed,
generating a mature RISC. Due to central mismatches in most miRNA duplex, the
miRNA duplex dissociates by unwinding instead of AGO2-mediated cleavage of the
passenger strand (Rand et al., 2005). The unwinding of miRNA duplexes is facilitated by
the presence of mismatches at the seed and 3’mid regions (Kawamata et al., 2009; Yoda
et al., 2010). The selection of guide miRNA strand is performed during the AGO loading
step, based on two factors: (i) lower internal stability at the 5’ end (Khvorova et al., 2003);
(ii) an uracil at nucleotide position 1 (Hu et al., 2009).
1.3.2 Gene silencing by microRNAs
As mentioned above, three of four human AGOs do not have endonucleolytic
activity. Furthermore, only a few miRNA-target pairs have nearly perfect
complementarity to guide AGO2 to cleave the targets (Karginov et al., 2010; Shin et al.,
2010). Take together, miRNAs in mammals regulate gene silencing mainly through
endonucleolytic cleavage-independent mechanisms, which are translational repression
and mRNA decay or degradation (Huntzinger et al., 2011). For translational repression,
the repression can occur either at initiation (Humphreys et al., 2005; Pillai et al., 2005) or
at the post-initiation stage (Nottrott et al., 2006; Petersen et al., 2006). In the pathway of
mRNA decay, AGO and its downstream effector GW182 (contains multiple glycinetryptophan repeats) interact with cytoplasmic poly(A)-binding protein (PABPC) (Fabian
et al., 2009; Zekri et al., 2009) and trigger deadenylation mediated by CAF1-CCR4-NOT
deadenylase complex (Behm-Ansmant et al., 2006; Piao et al., 2010). Decapping then
occurs after deadenylation, in which eukaryotic translation initiation factors (eIFs)
associated with 5’ cap are removed by decapping enzyme DCP2 and its cofactors
(Rehwinkel et al., 2005). Decapped mRNAs are rapidly degraded by the cytoplasmic 5’to-3’ exonuclease XRN1.
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However, it had not been clear whether translational repression or mRNA decay is
predominant in miRNA-mediated gene silencing until recently. One study examined the
efficiency of mRNA translation in vivo through polysome profiling and revealed that
reduction in mRNA translation can explain about 25% of gene silencing (Hendrickson et
al., 2009). Ribosome profiling experiments in mammalian cells, a method that determines
the positions of ribosomes on cellular mRNAs, suggest that at least 84% reduction in
protein production is attributable to decreased mRNA levels, whereas reduced
translational efficiency can account for 11-16% of protein repression (Guo et al., 2010).
The study also indicates that translational repression mainly occurs at initiation, rather
than ribosome drop off at the post-initiation stage, because down-regulation of ribosome
levels happens uniformly along the length of the open reading frame. In conclusion, rapid
mRNA degradation plays a predominant role in miRNA gene silencing.
1.3.3

microRNAs in the inner ear

Over 300 miRNAs have been reported to be expressed in mouse and rat inner ear by
microarray analysis (Elkan-Miller et al., 2011; Friedman et al., 2009a; Patel et al., 2013;
Wang et al., 2010; Weston et al., 2006; Zhang et al., 2013a). More recently, highthroughput RNA sequencing, which can identify novel RNA molecules compared to
known miRNAs identified in microarray, has found over 500 miRNAs expressed in the
mouse inner ear (Rudnicki et al., 2014b). The specific localization of some of these
miRNAs has been determined by in situ hybridization in mouse inner ear, shown in Table
1-1 (reviewed in (Patel et al., 2012)). The best-characterized miRNA cluster in the inner
ear is the miR-183 family composed of miR-183, miR-96 and miR-182, which will be
discussed in detail in the following section.
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Table 1-1 miRNA expression in the mouse inner ear
miRNA

Age
E9.5
E10.5
E11.5
E12.5

E14.5

E15.5
miR183/96/182

E16.5
E17.5
E18.5

Tissue
182/183 in otic vesicle
182 in otic vesicle
otic vesicle
vestibule, cochlear duct cells
CVG
HCs in luminal layer of vestibule
SG, vestibular SE
182 in SG, lower epithelial ridge, greater
epithelial ridge (GER)
GER, SG, cochlear duct cells, SE
182 in GER, SG, cochlear HCs, vestibule
CVG, transient cells of GER, SE
GER, SE, cochlear and vestibular HCs
CVG, cochlear and vestibular HCs
cochlear and vestibular HCs, CVG

P0

cochlear and vestibular HCs, SG
182 in cochlear and vestibular HCs, SG

P1
P0-P2
P4-P11
P4-P8
P4-P14
P11
P37-P100

182 in cochlear and vestibular HCs, SG
cochlear and vestibular HCs, SG
96 in inner sulcus, spiral limbus
182/183 in cochlear and vestibular HCs
SG
182/183 in inner sulcus, spiral limbus
cochlear HCs

Reference
(Sacheli et al., 2009)
(Wang et al., 2010)
(Sacheli et al., 2009)
(Sacheli et al., 2009)
(Weston et al., 2011)
(Sacheli et al., 2009)
(Weston et al., 2011)
(Wang et al., 2010)
(Sacheli et al., 2009)
(Wang et al., 2010)
(Weston et al., 2011)
(Sacheli et al., 2009)
(Weston et al., 2011)
(Weston et al., 2006;
Weston et al., 2011)
(Sacheli et al., 2009)
(Friedman et al.,
2009a)
(Wang et al., 2010)
(Sacheli et al., 2009)
(Sacheli et al., 2009)
(Sacheli et al., 2009)
(Sacheli et al., 2009)
(Sacheli et al., 2009)
(Weston et al., 2011)
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Table 1-1 Continued
miRNA

Age

miR-15a

P0

miR-18a

P0

miR-30b

P0

miR-99a

P0

miR-100a
miR-124a

P5
P5

Tissue
cochlear HCs and SCs, basilar membrane,
vestibular HCs, SG
cochlear and vestibular HCs, SG
cochlear HCs and SCs, basilar membrane,
vestibular HCs, SG
cochlear HCs and SCs, basilar membrane,
vestibular HCs, SG
vestibular ganglion (VG)
CVG

miR-135b

P0

vestibular HCs, CVG

miR-140
miR-194
miR-199a
miR-200b

P1
P1
P0
P0

miR-205

P0

miR-224

P0

miR-67155p/3p

P0

cochlear and vestibular HCs
cochlear and vestibular HCs, SG
cochlear cells
cochlear and vestibular epithelial cells
cochlear cells, spiral ligament cells,
Reissner’s membrane, basilar membrane,
apical spiral limbus
cochlear HCs and SCs, spiral limbus,
habenula perforate region, vestibular HCs
Cochlear and vestibular hair and SCs, CVG,
stria vascularis, basilar membrane, Reissner’s
membrane

Reference
(Friedman et al., 2009a)
(Friedman et al., 2009a)
(Friedman et al., 2009a)
(Friedman et al., 2009a)
(Weston et al., 2006)
(Weston et al., 2006)
(Elkan-Miller et al.,
2011)
(Wang et al., 2010)
(Wang et al., 2010)
(Friedman et al., 2009a)
(Hertzano et al., 2011)
(Elkan-Miller et al.,
2011)
(Rudnicki et al., 2014a)
(Rudnicki et al., 2014b)
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To elucidate the roles of miRNAs in inner ear, several mutant mouse models have
been developed, in which Dicer involved in miRNA biogenesis is completely or
conditionally knocked out. The development of dicer complete knockout mouse is
arrested during early gestation, suggesting that small RNAs play an indispensible role in
embryo development (Bernstein et al., 2003). Dicer CKO mice are then generated using
Cre-loxP recombination system, in which the expression of Cre recombinase is controlled
under different promoters, shown in Table 1-2. Pax2-Cre Dicer CKO mouse has
developmental defects in mid-hindbrain, kidney and inner ear and dies at E18.5 (Soukup
et al., 2009). Cre expressed in otic placode at E8.5 induces the ablation of Dicer, resulting
in loss of AC and LC, truncated cochlea with unusual stereocilia organization, and loss of
sensory neurons. Foxg1-Cre mediated Dicer ablation in neurosensory cells results in
complete loss of certain areas of the brain, near complete loss of the inner ear and
reduction of the eye and olfactory bulb (Kersigo et al., 2011). The inner ear at E18.5 is
smaller in size with less ossification and has only one small patch of HCs.
Pou4f3-Cre Dicer CKO mouse is generated to study the function of Dicer in HC
development. Pou4f3 is known to be expressed from E14.5 in mouse cochlea. The
cochlea has normal morphology at P0, but degenerates by P38 with no response to sound
stimuli detected by auditory brainstem response (Friedman et al., 2009a). Cochlear HCs
at P38 have aberrant shapes with no stereocilia or disorganized stereocilia. The severity
of the HC phenotype varies longitudinally along the cochlea, with basal HCs showing
more severe malformations. Another hair-cell specific Dicer CKO mouse is generated
using the Atoh1 promoter. As mentioned earlier, Atoh1 is expressed in all HCs at E12.5E14.5. Similar to Pou4f3-Cre Dicer CKO, Atoh1-Cre Dicer CKO mouse has normal HC
patterning at P16, but loss of HCs from base to apex at P28, mainly outer HCs (Weston et
al., 2011). Taken together, miRNAs play an important role in inner ear early development
and HC maintenance.
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Table 1-2 Conditional Dicer knockout in the inner ear and auditory brainstem
Cre
promoter

Cre expression

miRNA
depletion
E11.5: miR124
depletion
E17.5: miR183 residual
expression

Pax2

E8.5: otic placode

Foxg1

E12.5:
neurosensory cells
in inner ear

E12.5: miR124
depletion

Atoh1

E12.5-E14.5: HCs

P18: miR183 residual
expression

Pou4f3

E12.5: vestibule
E14.5: cochlea
and vestibule
P6: cochlear HCs
and some SCs,
vestibular HCs

Egr2

E8: rhombomeres
3 and 5

Atoh7

E12.5-E17: bushy
cells of ventral
cochlear nuclei

Inner ear/brainstem
defects

Lethality

Reference

E17.5: truncated
inner ear structures,
no AC and LC

E18.5

(Soukup et
al., 2009)

perinatal
stage

(Kersigo et
al., 2011)

P28

(Weston et
al., 2011)

/

(Friedman et
al., 2009a)

/

(Rosengauer
et al., 2012)

/

(Rosengauer
et al., 2012)

E18.5: near complete
loss of the entire ear
with only one patch
of HCs
P16: normal
morphology
P28: loss of HCs,
mainly OHCs
E18 and P0: normal
morphology
P38: aberrant
cochlear HCs from
base to apex,
stereocilia defects
P0: reduced volume
of cochlear nucleus
complex and
superior olivary
complex
Normal formation of
cochlear nucleus
complex
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The role of miRNAs is also studied in auditory brainstem. Early embryonic Dicer
knockout mediated by Erg2-Cre recombination leads to smaller cochlear nucleus
complex and superior olivary complex in the brainstem at P0 (Rosengauer et al., 2012).
However, mid-embryonic ablation of Dicer using Atoh7-Cre in the ventral cochlear
nucleus results in normal formation of the cochlear nucleus complex.
The identification of direct targets of miRNAs is necessary to understand the
mechanisms of miRNA regulation of development, shown in Table 1-3 for the inner ear.
Potential targets can be predicted by bioinformatic algorithms based on sequence
complementarity between miRNAs and mRNA 3’UTRs, sequence conservation, and free
energy binding, such as TargetScan, PicTar and MicroCosm (Krek et al., 2005; Lewis et
al., 2005; Peterson et al., 2014; Witkos et al., 2011). The repression of predicted miRNA
targets needs to be verified by experimental approaches. The most commonly used
technique is a luciferase assay, in which the 3’UTR of a predicted target is inserted after
the luciferase open reading frame. A vector carrying the luciferase-3’UTR fusion gene
and either a vector carrying a miRNA gene or a miRNA synthetic mimic are transfected
into cell lines. If the predicted target is a real target, miRNA can recognize the binding
site in the 3’UTR and repress the production of luciferase protein, leading to decreased
bioluminescence. However, the disadvantage of this in vitro assay is the loss of
endogenous context, both at the level of target sequence within its mRNA and at the level
of cellular context (Pasquinelli, 2012). One in vivo approach for target verification is to
use anti-sense morpholinos to repress endogenous miRNAs and detect changes in the
level of target mRNAs or proteins.
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Table 1-3 Verified gene targets of miRNAs in the inner ear
miRNA

miR-96

Gene target
Aquaporin 5 (Aqp5)
Cadherin, EGF LAG
seven-pass G-type
receptor 2 (Celsr2)
Myosin VIIA and Rab
interacting protein (Myrip)
Outer dense fiber of sperm
tails 2 (Odf2)
Receptor-like tyrosine
kinase (Ryk)

miR-96/182

Chloride intracellular
channel 5 (Clic5)

miR-182

SRY-box containing
transcription factor (Sox2)

miR-182

T-box1 (Tbx1)

miR-183

TAO kinase 1 (Taok1)
Early growth response 1
(Egr1)
Insulin receptor substrate 1
(Irs1)

Experimental approach

Reference

Luciferase assay in NIH 3T3
cells; expression in the inner ear

(Lewis et al.,
2009; Mencía
et al., 2009)

Luciferase assay in A549 cells;
Clic5 expression mouse auditory
HEI-OC1 cells; repressed Clic5
expression in HEI-OC1
transfected with miRNA mimics
Luciferase assay in HEK293
cells; Sox2 expression in HCs
Luciferase assay in COS1 cells;
corresponding Tbx1 expression in
otic progenitor cells treated with
miR-182 or its inhibitor
Upregulation in rat cochlear
organotypic cultures transfected
with miR-183 antisense
morpholino

(Gu et al.,
2013)
(Weston et al.,
2011)
(Wang et al.,
2012b)

(Patel et al.,
2013)
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Table 1-3 Continued
miRNA

miR-15a

Gene target
Solute carrier family 12
(sodium/potassium/chloride
transporters), member 2
(Slc12a2)
Claudin 12 (Cldn12)
Brain-derived neurotrophic
factor (Bdnf)

miR-135b

PC4 and SFRS1 interacting
protein 1 (Psip1-p75)

miR-200b

Zinc finger E-box binding
homeobox 1 (Zeb1)

miR-224

Pentraxin 3 (Ptx3)

miR6715-3p

Rho GTPase activating
protein 12 (Arhgap12)

Experimental approach

Reference

Luciferase assay in HEK293T
cells; expression in the inner ear

(Friedman et
al., 2009a)

Luciferase assay in MCF-7 cells;
increased expression in Cal51 cells
transfected with shRNA targeting
miR-135b; complimentary
expression in the inner ear
Luciferase assay in SW480 cells;
complimentary expression in the
inner ear
Luciferase assay in HEK293T
cells; repressed protein expression
by miR-224 in NIH3T3 cells
Luciferase assay in HEK293T
cells; Arhgap12 expression in
inner ear

(Elkan-Miller
et al., 2011)
(Burk et al.,
2008; Hertzano
et al., 2011)
(Rudnicki et al.,
2014a)
(Rudnicki et al.,
2014b)
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Age-related hearing loss is a progressive sensorineural hearing loss that affects older
people. More than four million Americans age 65 and older have reported to have hearing
loss. In general, degeneration of organ of Corti is the main cause of age-related hearing
loss. To determine whether miRNAs are involved in this process, miRNA expression in
mouse organ of Corti is compared at different ages (Zhang et al., 2013a). Substantially
more miRNAs (including miR-181a and 183) are downregulated in comparison to the
number of miRNAs that are upregulated (including miR-29a and 34a) during aging.
The avian BP can regenerate HCs spontaneously after injury via SC
transdifferentiation and division, but mammalian organ of Corti cannot (Stone et al.,
2007). To elucidate the role of miRNAs in HC regeneration, microarray analysis is
performed on BP explant cultures treated with forskolin to activate SC proliferation
(Frucht et al., 2010). miR-181a is found to be upregulated in the proliferating tissue.
Functional experiments show that miR-181a overexpression is able to simulate
proliferation and generate new cells that are positive for myosin VI, one HC marker, and
inhibition of miR-181a via anti-miR-181a results in suppressed proliferation, suggesting
that miR-181a is necessary and sufficient for SC proliferation in the BP.
1.3.4

The miR-183 family

The miR-183 family consists of miR-183, miR-96 and miR-182, which is
transcribed as one polycistronic pri-miRNA (Xu et al., 2007). The mouse miR183/96/182 gene cluster is located in the intron of a potential protein-coding gene flanked
by Nrf1 and Ube2h (Lumayag et al., 2013). The seed region of the miR-183 family is
fully conserved throughout vertebrate evolution, as shown in Figure 1-5. They are
expressed in retina photoreceptors and interneurons, inner ear HCs and ganglia, olfactory
epithelia, cranial ganglia, dorsal root ganglia and some other neurosensory organs in
zebrafish and mouse (Kloosterman et al., 2006b; Weston et al., 2006; Wienholds et al.,
2005; Xu et al., 2007).
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Figure 1-5 Sequence comparison of the miR-183 family members
The sequences of mature miR-183, miR-96 and miR-182 are shown here in chicken (gga),
human (hsa), mouse (mmu) and zebrafish (dre). miR-96 is conserved among the four
species, while miR-182 and miR-183 show differences in the last few nucleotides at their
3’ ends. The shaded region illustrates their seed regions (nucleotides 2-7). Here, hsa-miR96/182/183, mmu-miR-96/182/183 and dre-miR-182 stand for hsa-miR-96/182/183-5p,
mmu-miR-96/182/183-5p and dre-miR-182-5p, respectively. The sequence of chicken
miR-183 (gga-miR-183) was obtained from the current miRNA database miRBase.
However, chicken miR-182 and miR-96 sequences were not included in the database.
Their sequences were obtained from published avian short RNA sequencing reads
(Powder et al., 2012).
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The expression pattern of miR-183 family is examined in the organ of Corti from
E14.5 to P100 by Weston and colleagues (Weston et al., 2011). They show that miR-183
family members exhibit dynamic apex-to-base gradients in maturating mouse cochlea:
higher expression in the base at P0 that gradually decreases toward the apex, but at P37,
this gradient is reversed with higher expression in the apex. These developmental
expression profiles led Weston et al., to propose that miR-183 members may establish
target gene expression gradients that can contribute to the acquisition of the longitudinal
tonotopy. The expression level of the miR-183 family also varies across the radial axis of
the mouse cochlea and this expression pattern changes with maturation as overall levels
decrease. At P0, the expression of the miR-183 family is higher in the OHCs than in the
IHCs. By P37, this pattern is reversed in the base of the cochlea, while levels in the apex
are similar across the radial axis, at least as assessed qualitatively by in situ hybridization.
Additional evidence linking the miR-183 family to longitudinal tonotopy in the cochlea
comes from gene expression gradients along the chicken BP (Frucht et al., 2011). Gene
sets with miR-96 or miR-182 recognition sites are enriched in the basal end of the BP,
suggesting that the miRNAs are upregulated in the apex.
Mutations in the MIR96 gene underlie inherited hearing loss in human (Mencía et al.,
2009; Soldà et al., 2012). Specifically, a G>A mutation at position 13 in one allele of
miR-96 is identified from an autosomal dominant deafness locus (DFNA50) in a Spanish
family with postlingual, progressive, nonsyndromic all-frequency hearing loss. A second
mutation MIR96(+14C>A) is identified in another family with autosomal dominant,
progressive, high-frequency hearing loss (Mencía et al., 2009). The two mutations
introduce a base-pairing mismatch and create an enlarged RNA bulge in the pre-miRNAs.
Processing of mutated miR-96 into mature miRNAs is impaired by 80% in HeLa cells
after transfection. Furthermore, the mutations in the seed region of miR-96 affect mRNA
target recognition, leading to derepression of luciferase reporters containing 3’UTRs of
miR-96 targets. A novel mutation MIR96 (+57T>C) in an Italian family with autosomal
dominant hearing loss is identified within the miR-96 gene but outside of the mature
miR-96 sequence (Soldà et al., 2012). The mutation resides in the passenger miR-96*
strand and impairs the processing of mature miR-96 by affecting the pre-mRNA
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secondary structure. Interestingly, the expression of miR-96 can be rescued by a
compensatory mutation that recovers the secondary structure of pre-miR-96 hairpin.
Further evidence of miR-96 involvement in genetic hearing loss arises from the Nethyl-N-nitrosurea-induced Diminuendo mouse model (Dmdo) with semidominant
hearing loss (Lewis et al., 2009). The mutation is identified to be an A>T substitution
within the seed region of miR-96. Dmdo homozygotes with complete hearing loss have
normal arrangement of HCs with irregular bundles at P5, but very few HCs at P28. The
heterozygotes with progressive hearing loss have normal HC bundles at P5, but many
OHCs have degenerated in the middle and basal turns by P28. The stereocilia in the
remaining HCs are not well organized. However, unlike the three miR-96 mutations in
human, the mutation in Dmdo does not affect miR-96 processing. Five genes (Slc26a5,
Ocm, Pitpnm1, Gfi1, and Ptprq) that play important roles in HCs are downregulated in
the Dmdo mutant organ of Corti, although they do not have binding sites for either
wildtype or mutant miR-96. Analysis to look at broader effects of miR-96 mutation on
mRNA profile shows that hundreds of genes upregulated in Dmdo mutants have miR-96
binding sites in their 3’UTRs, whereas mutant miR-96 binding sites are enriched in the
downregulated genes. Detailed examination of HC morphology and physiology, synaptic
morphology and innervation pattern in Dmdo mutant mice suggests that the development
of HCs is arrested at around P0, before their complete differentiation into IHCs and
OHCs (Kuhn et al., 2011). A main contributor of the phenotype observed in Dmdo is the
reduction in the level of Ptprq (protein tyrosine phosphatase, receptor type, Q), because
Dmdo heterozygotes and mice homozygous for a catalytically inactive allele of Ptprq
share a similar phenotype in morphology and electrophysiology, but less severe than
Dmdo homozygotes (Chen et al., 2014). Ptprq is expressed in hair bundles of HCs and
plays an important role in the maturation of hair bundles in both the cochlea and the
vestibule (Goodyear et al., 2012; Goodyear et al., 2003).
The functions of individual members in the miR-183 family are studied through
systematically regulating their expression levels in zebrafish embryos (Li et al., 2010b).
Antisense morpholino-mediated knockdown of the miR-183 family members leads to
fewer HCs within normal prosensory domains and smaller CVGs at 48 hours post

37
fertilization (hpf). Overexpression of miR-96 or miR-182, but not miR-183, via injection
of synthetic double-stranded miRNAs results in duplicated otocysts and ectopic or
expanded sensory patches at 26hpf (Li et al., 2010b). However, after one-day of
development, miR-182-injected embryos still have expanded sensory domains and
increased number of HCs, whereas miR-96-injected embryos have reduced number of
HCs compared with control embryos. Interestingly, miR-182 overexpression can partially
rescue the phenotype caused by miR-96 knockdown, suggesting some redundant roles
between miR-182 and miR-96 due to their identical seed region sequences. Taken
together, deficiencies and excesses of miR-183 family expression are both associated
with abnormal HC and neuron development, indicating that precise level of miR-183
family is critical in inner ear development.
Due to their specific expression in photoreceptors and interneurons in the inner
nuclear layer in the retina, the function of miR-183 family is also well studied in the
retina. An early study in mouse retina shows that miR-96 and miR-182 expression
display circadian variation with peak at Zeitgerber time 13 and suggests that they are
probably involved in circadian rhythm regulation by regulating the expression of
adenylyl cyclase VI (Adcy6) (Xu et al., 2007). A more recent study argues that miR-183
family as well as miR-204 and miR-211 are downregulated in the retina during dark
adaptation and upregulated during light adaptation, independent of circadian rhythm,
which arises from rapid decay and increased transcription respectively (Krol et al., 2010).
SLC1A1 encoding a voltage-dependent glutamate transporter is identified as one
common target of the miR-183/96/182 cluster in the photoreceptors.
To elucidate the function of the miR-183 family in the retina, a sponge transgenic
mouse model is generated to disrupt their activities in the retina (Zhu et al., 2011).
Although no morphological and functional differences are observed under normal
laboratory lighting conditions, severe retinal degeneration with reduced thickness of outer
nuclear layer in superior retina occurs in sponge transgenic mice after acute bright light
exposure. Of note, inhibition of Casp2 that is a direct target of miR-96/182 and is
involved in apoptosis can partially relieve light-induced retinopathy in the sponge
transgenic mice. Recently, a miR-183/96/182 knockout mouse model has been generated
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using a gene-trap embryonic stem cell clone (Lumayag et al., 2013). Loss-of-function of
the miR-183 family leads to progressive retinal degeneration, increased susceptibility to
light damage, early-onset and progressive photoreceptor ribbon synaptic defects and
corresponding abnormal scotopic and photopic electroretinograms with decreased b-wave
amplitudes. To figure out the function of miRNAs in adult cones, a mouse model is
developed in which conditional Dgcr8 knockout results in miRNA depletion in adult
cones (Busskamp et al., 2014). The cones in the mutant mouse lose their outer segments
gradually from P30 to P60 and show reduced responses to light together with gradual loss
of cone-specific gene expression, which can be prevented by re-expression of miR182/183 via AAVs encoding short hairpin RNAs that resemble pre-miR-183 and premiR-182.
1.4

Study objectives and significances

It is hypothesized that the expression gradients of the miR-183 family along and
across the mammalian cochlear axes are meaningful for HC development, and thus would
be evolutionarily conserved in the avian BP. The objectives of this study are to (1) to
explore expression patterns of the miR-183 family in chicken inner ear; (2) to look at the
effects of misexpression of the miR-183 family on HC differentiation along and across
the BP and HC commitment outside and inside the sensory domains; (3) to verify some
gene targets of miR-182.
Hearing loss is a common human sensory deficit. About 20 percent of Americans
aged 12 years or older (48 million) have some degree of hearing loss in one ear or both
ears (Lin et al., 2011). Sensorineural hearing loss occurs when there are defects in the
cochlear or in the nerve pathway from the inner ear to the brain, which is the most
common type of hearing loss. Sensorineural hearing loss can arise from heredity, ototoxic
drugs, aging, loud noise exposure, head trauma, etc. Human patients with hearing loss
can wear hearing aids to amplify sound stimuli or use cochlear implants sending electric
impulses to auditory nerves. However, no biological therapeutic strategies are currently
available for patients. Acoustic researchers are focusing on recovery of dysfunctional
HCs and regeneration of HCs either by SCs or by embryonic stem cells, for example by
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manipulating different transcription factors. miRNAs are also good candidates, as each
miRNA can modulate the expression of hundreds of protein-coding genes. Understanding
the function of miRNAs in HC development and maintenance will provide possible
strategies in HC regeneration in future.
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CHAPTER 2. MATERIALS AND METHODS

2.1

Animals

Fertilized White Leghorn chicken eggs were purchased from Purdue University
Animal Sciences Education and Research Center and were stored at 12 °C before
incubation. The eggs were incubated at 37-39°C in a humidified incubator and the
embryos were removed from the eggs to cold phosphate buffered solution (PBS; pH 7.4)
and staged (S) according to Hamburger and Hamilton developmental stages (Hamburger
et al., 1992). E5-E7 embryo heads were fixed in 4% paraformaldehyde (PFA) in PBS
overnight at 4°C and then rinsed in PBS for 1 hour. E12-E18 embryo heads were fixed in
4% PFA in PBS overnight at 4°C after the removal of the tympanic membrane and the
columellas to expose the oval window. The embryonic cochlear duct was dissected from
surrounding temporal bone and the auditory nerve in cold PBS. Abneural limbus,
tegmentum vasculosum and tectorial membrane were removed to isolate the BPs.
2.2

Cryosectioning

The tissues for cryosectioning, embryo heads at E5-E7 or isolated BPs at E12 and
beyond, were cryoprotected by going through 10%, 20% and 30% sucrose in PBS with
0.05% sodium azide. For section in situ hybridization, the tissues were embedded in
Tissue Freezing Media (Triangle Biomedical Sciences) or Optimal Cutting Temperature
Compound (Tissue-Tek). For section immunostaining or sectioning after whole-mount in
situ hybridization, the tissues were embedded in 300 bloom gelatin (7.5% gelatin, 15%
sucrose, 0.05% sodium azide in PBS). The tissues were frozen on a metal stand sitting in
liquid nitrogen and were moved into -80°C for long-term storage. At about -22°C, frozen
sections of 15µm thickness were collected onto superfrost/plus microscope slides (Fisher
Scientific). The embryo heads were sectioned horizontally from dorsal to ventral (shown
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Figure 2-1 Lateral views of the chicken inner ear at E5 and E7
The left two images are lateral views of the fluid labyrinth of the inner ear at E5 and E7.
The right image is an E7 chicken embryo head that shows the position of the right ear
inside the head. The dashed lines illustrate the orientation of horizontal sections across
the inner ear. Modified from Bissonnette & Fekete, 1996 (Bissonnette et al., 1996).
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in Figure 2-1) or transversely from anterior to posterior. The isolated BPs were sectioned
transversely from base to apex. Two or three series of sections were collected to perform
different experiments on alternate sections. The sections were air dried for least 20
minutes and then stored at -20°C.
2.3

Section in situ hybridization

The protocol of section in situ hybridization was adapted from a published protocol
(Obernosterer et al., 2007). The sections were fixed in 4% PFA for 10 minutes, rinsed in
PBS three times for 5 minutes, treated with 1 µg/ml proteinase K in PBS for 10 minutes,
post-fixed for 10 minutes, and rinsed in PBS three times for 5 minutes. After acetylation
in 0.1M triethanolamine and 0.25% acetic anhydride in H2O for 10 minutes and wash in
PBS three times for 5 minutes, the sections were pre-incubated in hybridization buffer
(10% dextran sulfate, 50% formamide, 500 µg/ml yeast torula RNA, 1X Denhart’s
solution, 0.3 M NaCl, 8.9 mM Tris HCl, 1.18 mM Tris base, 5 mM NaH2PO4, 5mM
Na2HPO4, 5mM EDTA in H2O) at room temperature for 2 hours and then incubated with
20 nM 3’-Digoxygenin (DIG) labeled locked nucleic acid (LNA) probes (Exiqon) in
hybridization buffer overnight at 50-56 °C covered by RNase-free plastic coverslips in a
hybridization chamber (humidified with 50% formamide and 5X saline-sodium citrate
buffer (SSC)). The LNA probes used in this study were dre/hsa-miR-183 (3500505/38490-05, recommended hybridization temperature is 30°C below RNA Tm, 54°C),
hsa-miR-96 (38474-05, 52°C) and dre-miR-182 (35003-05, 56°C).
On the second day, the coverslips were removed carefully from the slides in prewarmed 5X SSC. The sections were washed in 0.2X SSC at hybridization temperature for
1 hour and in B1 buffer (100 mM Tris pH 7.5, 0.15 M NaCl in H2O) at room temperature
twice for 5 minutes. To reach RNase-free conditions, the glassware that had been baked
at 180°C for at least 4 hours and diethylpyrocarbonate-treated H2O was used in preparing
all the solutions used before the step of washing in B1 buffer. The sections were then
blocked in blocking solution (10% heat-inactivated goat serum in B1 buffer) at room
temperature for 1 hour and incubated with sheep polyclonal IgG anti-DIG-alkaline
phosphatase FAB fragments (Roche 11093274910, 1:2000) diluted in blocking solution
at 4°C overnight.
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microRNA

LNA

DIG
NBT & BCIP
AP

Purple reaction

Figure 2-2 Schematic of microRNA in situ hybridization
The expression of microRNAs is detected by in situ hybridization, in which locked
nucleic acid probe with a 3’ Digoxigenin label binds with their microRNA target. An
antibody conjugated with alkaline phosphatase will recognized DIG and substrates of
alkaline phosphatase, NBT and BCIP will form purple precipitates so that we can
visualize the spatial expression of microRNAs.
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On the third day, the sections were washed in B1 buffer three times for 5 minutes
and in alkaline phosphatase buffer (100mM Tris pH 9.5, 100 mM NaCl, 50 mM MgCl2 in
H2O) twice for 5 minutes. The sections were then incubated with 330 µg/ml nitro-blue
tetrazolium chloride and 160 µg/ml 5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt
(Roche) in alkaline phosphatase buffer for purple color reaction. The color reaction took
from several hours at room temperature to two days at 4°C. The reaction was stopped
through rinsing in 1mM EDTA in PBS for 10 minutes. The sections were dehydrated
through graded ethanol solutions (50%, 70%, 95% twice, 100% twice) and Hemo-De
(Scientific Safety Solvents) three times and coverslipped with ShurMount mounting
medium (Triangle Biomedical Sciences).
2.4

Whole-mount in situ hybridization

The isolated BPs from E12-E18 chicken embryos went through graded methanol
(25%, 50%, 75%, 100%) for dehydration and were stored at -20°C no longer than four
weeks before in situ hybridization. Whole-mount in situ hybridization was performed as
previously described (Kloosterman et al., 2006b; Li et al., 2010b). The BPs were first
rehydrated through graded methanol (75%, 50%, 25%) for 5 minutes in each solution and
washed in PTW (0.1% Tween-20 in PBS) four times for 5 minutes. They were then
treated with 5 µg/ml proteinase K for 7 minutes, fixed in 4% PFA for 20 minutes and
rinsed in PTW five times for 5 minutes and in hybridization buffer (50% formamide, 5X
SSC, 0.1% Tween-20, 9.2 mM citric acid, 500 µg/ml yeast torula RNA, 50 µg/ml heparin
in H2O) for 5 minutes. They were pre-incubated in hybridization buffer for 2-3 hours at
hybridization temperature and then hybridized with 20 nM LNA probes in hybridization
buffer overnight at 52 °C. It seems like the probability of tissue shrinking and curling
increases with higher hybridization temperature. Thus, I used 52 °C for miR-183 and
miR-182 instead of their optimal hybridization temperature (54 °C and 56 °C).
On the second day, the BPs went through stringency washes in 100% posthybridization buffer (50% formamide, 5X SSC, 0.1% Tween-20, 9.2 mM citric acid in
H2O), 25% 2X SSCT (SSC with 0.1% Tween-20) in post-hybridization buffer, 50% 2X
SSCT, 75% 2X SSCT, 100% 2X SSCT for 15 minutes and in 0.2X SSCT twice for 30
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minutes at hybridization temperature. They were further rinsed in 75% 0.2X SSCT in
PTW, 50% 0.2X SSCT, 25% 0.2X SSCT and PTW for 10 minutes at room temperature.
The BPs were blocked in blocking buffer (2% heat-inactivated goat serum, 2 mg/ml
bovine serum albumen in PTW) for 1 hour and then incubated with anti-DIG-alkaline
phosphatase FAB fragments (1:2000) in blocking buffer overnight at 4°C.
On the third day, the BPs were first washed six times in PTW for 15 minutes. After
the post-antibody washes, the BPs were rinsed three times in alkaline phosphatase buffer
with 0.1% Tween-20 for 5 minutes. They were then incubated with 330 µg/ml nitro-blue
tetrazolium chloride and 160 µg/ml 5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt
(Roche) in alkaline phosphatase buffer with 0.1% Tween-20 for purple color reaction for
several hours at room temperature to several days at 4°C. After the color reaction, the
BPs were first rinsed in 1 mM EDTA in PTW for 10 minutes and post-fixed in 4% PFA
for 10 minutes. The BPs went through graded methanol (25%, 50%, 75%, 100%, 75%,
50%, 25%) for five minutes in each solution for tissue clarification and then were washed
in PBS for 5 minutes before mounting in glycerol or VectaShield mounting medium
(Vector Labs).
2.5

Plasmid construction

The plasmids pCAG-T2TP (abbreviated pT2TP) encoding Tol2 transposase and
pT2K-CAG-EGFP (abbreviated pGFP) carrying Tol2 sites were kindly given by Koichi
Kawakami (National Institute of Genetics, Japan) and Yoshiko Takahashi (University of
Tokyo, Japan) (Kawakami, 2007; Sato et al., 2007). pGFP was first modified into a
Gateway destination vector (pT2K-CAG-EGFP-attR) by inserting attR cassette
(Invitrogen) into the unique EcoRV site located after the GFP coding sequence. An
approximately 800 base pair fragment containing genomic sequences from the mouse
miR-183 family locus, flanked by splicer donor and acceptor sites, was obtained from
pME-MCS-sd-miR183F-sa (Stoller et al., 2013). The miR-183 family intron was then
integrated into pT2K-CAG-EGFP-attR through a Gateway LR recombination reaction,
creating pT2K-CAG-EGFP-183F (abbreviated pGFP-183F). The reactions followed the
manufacturer’s protocols (Invitrogen Gateway Technology). The hypothesized
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processing pathway of transfected pT2TP and either pGFP or pGFP-183F is shown in
Figure 2-3.
2.6

Making electrodes

The protocol of making electrodes was kindly provided by Ulrike Sienknecht.
Tungsten wire (Alfa Aesar #10409 0.5mm/0.02in), platinum wire (WPI PTP101
0.25mm/0.01in) and heat shrink tube (FPS-003-6040-BLK) were used. The procedure
was: (1) cut two tungsten wires of 4-5cm in length and make them straight; (2) cut two
platinum wires of ~1cm in length; (3) cut two heat shrink tubes of 3-4cm in length; (4)
insert the tungsten wire into one heat shrink tube, so that the tungsten wire just sticks out
at one end; (5) insert the platinum wire ~0.5cm into the end of the tube where the
tungsten wire just sticks out; (6) use flame to melt the heat shrink tube, so that the
platinum and tungsten wires are wrapped tightly; (7) melt together two electrodes or use
Parafilm M to hold together two electrodes; (8) bend the platinum wires 2-3mm into a
45°-60° angle; (9) use nail polish to insulate the unbent platinum wires and the tungsten
wires that just stick out; (10) place the pair of electrodes into electrode holder and
connect the other ends of the tungsten wires to cables from an electroporator.
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Figure 2-3 Hypothesized processing of pT2TP and either pGFP or pGFP-183F
pT2TP encodes Tol2 transposase under the control of a ubiquitous promoter in chicken
cells, CAGGS (Niwa et al., 1991). The expressed Tol2 transposase recognizes Tol2 sites
in pGFP or pGFP-183F and drives the integration of the sequence flanked by Tol2 sites
into the host genome. The black arrowheads in the boxes of Tol2 ends indicate 12 base
pair terminal inverted repeats. Transfection of pT2TP and pGFP leads to stable
expression of GFP protein with green fluorescence. Transfection of pT2TP and pGFP183F results in stable expression of GFP protein and mature miR-183 family members.
The hypothesized processing of the intronic miRNAs follows a canonical miRNA
biogenesis pathway, as shown in Figure 1-4. m7G: 7-methylguanosine cap; ORF: open
reading frame.
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2.7

Electroporation of chicken otic cup or otocyst

The eggs were windowed at E2 and plasmids were electroporated into the otic cup at
S11-S12 or into the otocyst at S14-S17. Chick Ringer’s solution (123.2mM NaCl, 1.56
mM CaCl2, 4.96 mM KCl and 0.81 mM Na2HPO4 in H2O, pH 7.4) was added to keep the
embryos moisturized. The chorion and amnion were opened to expose embryo heads.
Pulled-glass capillary micropipettes with 10-12µm tips were loaded with concentrated
plasmids (3-5 µg/µl) diluted with 1/10 volume of 0.25% fast green dye. All the injections
in vivo in this study were performed with a mixture of the Tol2 transposase vector pT2TP
and either pGFP or pGFP-183F. The molar ratio of pT2TP to the GFP plasmids was in
the range of 0.75 to 1. The right otic cup or otocyst was injected using a Picospritzer II
(Parker Hannifin Corporation). After injection, electroporation was done using a TSS20
ovodyne electroporator and an EP21 current amplifier (Intracel). The electroporation
condition was 10 V, 2 pulses, 50 milliseconds width, and 10 milliseconds space between
the two pulses. In order to drive the plasmid expression in the BP, the plasmids need to
be driven into medial-posterior region of the otic placode from where the BP primordium
originates (Bell et al., 2008; Sánchez-Guardado et al., 2014). For S11-S12 embryos with
their dorsal sides facing up, the two platinum electrodes (Battisti et al., 2014) were placed
on either side of the embryo at the level of the otic cup, with the negative electrode on the
right side and the positive electrode on the left side, as previously described
(Chrysostomou et al., 2012). For S14-S17 embryos with their right sides facing up, the
negative platinum electrode was placed above the right otocyst and the positive electrode
was pushed underneath the left otocyst.
A total of 896 embryos received pGFP-183F and pT2TP and 325 embryos received
pGFP and pT2TP. Embryos were sacrificed and staged 2-14 days after electroporation.
The majority of embryos were intended for analysis 2 weeks after electroporation.
However, few survived to this time point (13% survival for pGFP and 11% survival for
pGFP-183F). I also noticed that electroporated embryos that were sacrificed at E14-E16
were 1-3 days younger in their Hamburger and Hamilton developmental stages than
expected. Therefore, to be accurate, the developmental stages of the embryos were used
instead of their embryonic ages.
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2.8

Immunofluorescence

For whole-mount immunostaining, after the BPs were dissected from fixed E12-E16
chicken heads, they were first rinsed with PBST (PBS with 0.1% triton) three times for
30 minutes and then incubated in blocking solution (10% goat or 5% horse serum and
0.05% sodium azide in PBST) for at least one hour. The BPs were then incubated in
primary antibodies diluted in 10% goat or 2% horse serum and 0.05% sodium azide in
PBST overnight at 4°C. Primary antibodies used here were mouse monoclonal IgG2a
anti-otoferlin HCS-1 (Developmental Studies Hybridoma Bank, 1:200), rabbit polyclonal
IgG anti-GFP (Life Technologies A11122, 1:5000), mouse monoclonal IgG1 anti-Ctbp2
(BD Transduction Labs 612044, 1:300) and goat polyclonal IgG anti-Sox2 (Santa Cruz
Biotechnology, 1:500 diluted in 2% horse serum). On the second day, after extensive
washes in PBST three times for 30 minutes, the BPs were incubated in AlexaFluorconjugated secondary antibodies (Life Technologies, AlexaFluor 488, 568 or 647, 1:500)
and phalloidin (Invitrogen, 1:500) diluted in 10% goat or 2% horse serum and 0.05%
sodium azide in PBST overnight at 4°C. They were then rinsed and mounted in
Vectashield hardset mounting medium. For counterstaining with a nuclei dye TO-PRO-3
(Invitrogen, 1:5000), the BPs were rinsed in PBST twice for 30 minutes after secondary
antibody incubation, incubated in TO-PRO-3 diluted in PBS for 1 hour at room
temperature, rinsed in PBS three times for 30 minutes and mounted in Vectashield
hardset mounting medium.
For section immunostaining, 15µm frozen sections from E5-E7 chicken embryos
were collected on slides. The section slides were first fixed in 4% PFA in PBS for 10
minutes, rinsed with PBS three times for 5 minutes, and then blocked in blocking solution
(10% goat serum, 0.05% triton, 0.05% sodium azide in PBS) for 1 hour. They were
incubated with primary antibodies (HCS-1 and anti-GFP) diluted in blocking solution at
room temperature for at least 1 hour or overnight at 4°C. After washes in PBS three times
for 5 minutes, they were incubated with secondary antibodies at room temperature for at
least 1 hour. They were then rinsed and coverslipped with Vectashield hardset mounting
medium.
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For DF-1 cell immunostaining, DF-1 cells reached about 95-100% confluence
before staining. The media was removed first and then the cells were rinsed in PBS twice
for 5 minutes before fixation in 4% PFA in PBS for 10 minutes. After washes in PBS
three times for 5 minutes, the cells were blocked in blocking solution (10% goat serum,
0.05% triton and 0.05% sodium in PBS) for 1 hour. They were then incubated in primary
antibody rabbit polyclonal IgG anti-GFP (Life Technologies A11122, 1:5000) diluted in
blocking buffer for 1 hour at room temperature. After washes in PBS three times for 5
minutes, the cells were then incubated in secondary antibody AlexaFluor 488 Goat-antiRabbit IgG (1:500) in PBS for 15 minutes at room temperature. The cells were rinsed in
PBS for 5 minutes before incubation in Hoescht 33342, trihydrochloride, trihydrate (Life
Technologies H3570, 1:10000) in PBS for nucleic acid staining. They were then rinsed in
PBS three times for 5 minutes and stored at 4°C until observations.
For neurofilament staining, the BPs after whole-mount in situ hybridization first
went through 10%, 20% and 30% sucrose and were embedded in 7.5% gelatin, 15%
sucrose, 0.05% sodium azide in PBS. Frozen sections of 15 µm thickness were collected
and fixed in 4% PFA for 15 minutes. After washes in PBS three times for 5 minutes each,
the sections were blocked with blocking buffer (10% calf serum, 0.05% triton and 0.05%
sodium azide in PBS) for 1 hour and then incubated with 3A10 (Developmental Studies
Hybridoma Bank, 1:20) diluted in blocking buffer overnight at 4°C. The sections were
then rinsed three times for 5 minutes on the next day and incubated in 0.3% hydrogen
peroxide in methanol at -20°C for 30 minutes to block endogenous peroxidase. After PBS
washes three times for 5 minutes, they were incubated with Biotinylated anti-mouse IgG
secondary antibody (Vector Labs, 1:250) in blocking buffer for one hour at room
temperature. The sections were rinsed in PBS three times for 5 minutes and incubated
with Vectastain ABC complex (Vector Labs, prepared 30 minutes before using) for 1
hour. They were then rinsed in PBS twice for 5 minutes and 50 mM Tris buffer (pH 7.5)
for 5 minutes and incubated with 0.5 mg/mL Diaminobenzidine (DAB) and 0.06% H2O2
in 50 mM Tris buffer (pH 7.5) for brown color reactions for 5-30 minutes. After washes
in PBS three times, the sections were dehydrated through graded ethanol and Hemo De
and coverslipped with ShurMount (Triangle Biomedical Sciences).
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2.9

Microscopy and image analysis

Images of in situ hybridization samples and immunostained sections were taken with
a Nikon Eclipse 800 and a SPOT Flex digital camera (Diagnostics Instruments, SPOT 5.1
software). Images of sections through the left ear and images of whole-mount left BPs
were flipped to facilitate comparisons with the right ear or the right BPs. Images of
immunostained whole-mount BPs were taken with a Nikon C1-plus confocal microscope.
60X confocal image stacks were taken at the base (~25%), middle (~50%) and apex
(~75%) along the BP (base was defined as 0% and apex 100%).
The size of HC maximum cross-section area was measured in ImageJ from HCS-1
staining at the base without viewing the GFP fluorescence in advance. After cross-section
area measurements, the HCs were then categorized into GFP+ and GFP- groups. The
number of ribbon synapses in GFP+ or GFP- HCs was counted as Ctbp2+ foci in HCs at
the base. The numbers of GFP+ HCs and GFP+ SC nuclei were counted in the confocal
image stacks by ImageJ software (NCBI) and the ratios of GFP+ SC/HC were calculated.
Student t-test and two-way ANOVA were performed. Graphs were made in Prism 6
software.
2.10 Cell culture and transfection
UMNSAH/DF-1 (abbreviated DF-1 cells, ATCC #CRL-12203) chicken embryo
fibroblast cells were cultured in DF-1 complete media (10% fetal calf serum, 2% chick
serum, 100 U/ml penicillin/streptomycin and 2 mM L-glutamine in Dulbecco’s Modified
Eagle’s medium (DMEM)) at 37°C with 5% CO2. They were split at 1:4 to 1:8 at 90%
confluence every two to three days.
To test the molar ratio of pT2TP to either pGFP or pGFP-183F for stable
transfection in vitro, the plasmids were first co-transfected into DF-1 cells and the
transfected DF-1 cells were maintained for 12-13 days before GFP immunostaining and
nuclei staining. 24 hours before transfection, DF-1 cells in 2 mL complete media were
plated into 35 mm petri dishes. The total DNA used per dish was 2-3 µg, but the molar
ratios of pT2TP to either pGFP or pGFP-183F varied among 0:1, 0.375:1, 0.75:1 and
1.5:1. The plasmid DNA was diluted in Optimem/Glutamax for a final volume of 250 µL.
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5µL Lipofectamine 2000 (Invitrogen) was gently diluted in 245 µL Optimem/Glutamax
and incubated for 5 minutes before being mixed with plasmid/miRNA solution. The
mixed transfection solution was incubated for 20 minutes at room temperature. The
growth media in the dishes were replaced with 1.5 mL transfection media (12% fetal calf
serum in Optimem/Glutamax). The 500 µL transfection solution was added on top of the
cells gently. After 6-hour incubation, the transfection mixture was removed and 2 mL
fresh DF-1 complete media was added.
Human embryonic kidney HEK293T/17 cells with SV-40 large T-antigen
(abbreviated HEK293T cells, ATCC #CRL-11268) were maintained in HEK293T
complete medium (10% calf serum, 100 U/ml penicillin/streptomycin and 2 mM Lglutamine in DMEM). They were cultured in 4 mL medium in a 60 mm petri dish at
37°C with 5% CO2. They were split at 1:4 to 1:8 at 90% confluence every two days, after
treatment with 0.25% Trypsin/0.53 mM EDTA.
For luciferase assay, 24 hours before transfection, about 5 x 104 HEK293T cells in
100 µL complete media were plated into each well in a 96-well plate to obtain
approximate 40% confluence. The confluence at the time of transfection was expected to
be at least 80%. 25 ng pSGG-3UTR firefly plasmids (SwitchGear Genomics), 5 ng pRLSV40 renilla plasmids (Promega) and 3.75 pmol double stranded-miRNA mimics
(Thermo Scientific Dharmacon, miR-182 or miRNA mimic negative control #1 5′ UCACAACCUCCUAGAAAGAGUAGA-3′) were diluted in Optimem/Glutamax to
reach final volume of 25 µL. 1µL Lipofectamine 2000 was gently diluted in 25 µL
Optimem/Glutamax and incubated for 5 minutes before being mixed with
plasmid/miRNA solution. The mixed transfection solution was incubated for 20 minutes
at room temperature and then was added to 100 µL transfection media. The growth media
were carefully removed from each well in the seeded plate and 150 µL transfection
mixture was then added into each well. After incubation at 37°C for 6 hours, the
transfection mixture was replaced with 100 µL HEK293T complete media.
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2.11 Luciferase assay
24 hours after transfection, the firefly and renilla luciferase levels of HEK293T cells
were measured with Dual-luciferase reporter assay (Promega E1910). The growth media
were removed from the cultured cells and then the cells were rinsed in PBS once. 20 µL
1X Passive lysis buffer was added into each culture well in the 96-well plate. The plate
was gently rocked for 15 minutes. Luciferase assay reagent II (LAR II) and Stop & Glo
reagent were prepared according to the manufacturer’s instructions. LAR II and Stop &
Glo reagents were connected to the injectors 1 and 2 of Luminoskan Ascent microplate
luminometer (Thermo Scientific), respectively. 100 µL LAR II was first dispensed to
measure firefly luciferase activity with 10-second exposure time. 100 µL Stop & Glo
were then added into the well to detect renilla luciferase activity. This cycle was repeated
for remaining wells in the 96-well plate.
Each firefly plasmid together with renilla plasmid were transfected into the cells of
three replicate wells. The resulting ratios of firefly luminescence to renilla luminescence
were calculated. The relative luciferase activity was calculated through dividing the
luminescence ratio in the presence of miR-182 by the average ratio in the presence of
negative control #1 miRNA. Each experiment was repeated independently at least twice.
Student t-test and one-way ANOVA were performed. Graphs were made in Prism 6
software.

54

CHAPTER 3. EXPRESSION OF THE MIR-183 FAMILY IN THE CHICKEN INNER
EAR

3.1

Expression of the miR-183 family in the vestibular organs at E5 and E7

In order to explore their temporal expression patterns during development, I
performed in situ hybridization of miR-183, miR-96 and miR-182 using inner ear
sections at S28 and S31 and whole-mount BPs at S38-S45. The three miRNAs shared a
similar expression pattern across this time period.
Section in situ hybridization images at E5/S28 and E7/S31 showed that miR-183,
miR-96 and miR-182 were expressed in the neurons of both VG and cochleolagenar
ganglion (CG) and in the vestibular HCs of AC, PC, LC, UM and SM (Figure 3-1, 3-2, 33). They were undetectable in LM at S28, but were present at S31. The presence of the
miR-183 family in both CVG neurons and immature HCs in chicken inner ear is
conserved as in the mouse inner ear (Sacheli et al., 2009; Weston et al., 2011).
I also compared the expression pattern of the miR-183 family relative to a HC
marker, otoferlin (HCS-1), using alternate sections (Figure 3-4). The miR-183 family was
present in a broader region of vestibular HCs than otoferlin that was barely detectable at
S28, suggesting that the miR-183 family comes up earlier than otoferlin in the
differentiating HCs. Similar to HCS-1 immunostaining (Goodyear et al., 2010), the miR183 family expression in the vestibular organs showed the presence of cytoplasmic tails
that extend toward the basal surface of the epithelium in immature HCs.
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Figure 3-1 Expression of miR-183 in the inner ear at S28 and S31
A-C: horizontal sections through the inner ear from a S28 chicken embryo. D-F:
transverse sections from a S31 chicken embryo. A, B, D, E: sections across the vestibular
organs. C, F: sections across the cochlear duct. A, B, C: miR-183 is weakly expressed in
the AC, PC, SM and the VG, but is absent in the cochlear duct at S28. D, E: miR-183 is
strongly expressed in HCs of the LC, UM, SM and LM. F: miR-183 is expressed at the
apex of the BP. It is also present in both VG and CG neurons. Abbreviations: A, anterior;
AC, anterior crista; BP, basilar papilla; CG, cochleolagenar ganglion; D, dorsal; LC:
lateral crista; LM: lagena macula; M, medial; PC, posterior crista; SM, saccular macula;
UM, utricular macula; VG, vestibular ganglion. Scale bar equals 100 µm.
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Figure 3-2 Expression of miR-96 in the inner ear at S28 and S32
A-C: horizontal sections through the inner ear from a S28 chicken embryo. D-J:
horizontal sections from a S32 chicken embryo. A, B, D, E, G, H, J: sections across the
vestibular organs. C, F, I: sections across the cochlear duct. A, B, C: expression of miR96 is detected in the AC, SM, UM and LC, but is not found in the cochlear duct at S28. D,
E, G, H, J: miR-96 expression is robust in HCs of all the three cristae and the three
maculae. F, I: expression of miR-96 is observed in the BP as a weak radial gradient at the
base (bracket) and HC-associated expression at the apex. miR-96 is also present in the
VG and CG neurons at both S28 and S32. Scale bar equals 100 µm.
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Figure 3-3 Expression of miR-182 in the inner ear at S28 and S31
A and B: horizontal sections through inner ear from a S28 chicken embryo (the same S28
embryo as in Figure 3-1). C-F: horizontal sections from S31 chicken embryo. A-D:
sections across the vestibular organs. E-F: sections across the cochlear duct. A, B: miR182 is present in the AC, PC, SM and VG. C, D: miR-182 is strongly expressed in the PC,
UM and SM. E: miR-182 is weakly expressed in the prosensory region at the base of the
BP with a neural-to-abneural gradient (bracket). F: miR-182 is expressed in the abneural
HCs at the apex of the BP. Scale bar equals 100 µm.
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Figure 3-4 Expression of miR-182 and otoferlin from adjacent sections at S28
A-D: horizontal sections from a S28 chicken embryo. A, B: sections across AC. C, D:
sections across the LC, UM and SM. A, C: miR-182 in situ hybridization. B, D: antiotoferlin (HCS-1) immunostaining. HCS-1 was barely detectable in the three vestibular
organs in D, whereas miR-182 expression was quite obvious in C.
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One remarkable difference among the three family members was that the miR-182
probe gave the most robust signal compared with miR-183 or miR-96 probes. This
difference in the signal level has also been reported in the mouse retina, as the level of
miR-182 was highest and miR-96 was lowest (Xu et al., 2007). The difference in signal
levels probably originates from relative level differences among the three miRNAs.
However, we could not exclude that the efficiencies of DIG-labeled LNA probes might
be different.
3.2

Expression of the miR-183 family in the cochlear duct at E7

At S28, the sensory precursors in the basal BP start to exit the cell cycle (Katayama
et al., 1989). At this stage, the miR-183 family showed no detectable expression along the
cochlear duct. At S31, the basal half of the BP is still at a prosensory stage. Sections
across the base of the cochlear duct showed faint expression of miR-183 (n=3/4 ears from
2 embryos, 50 °C hybridization temperature for one embryo and 52 °C for the other
embryo, Figure 3-1), miR-96 (n=2/5 ears from 3 embryos, 52 °C hybridization
temperature, Figure 3-2) and miR-182 (n=7/7 ears from 5 embryos, 52 °C hybridization
temperature for 2 embryos and 56 °C for 3 embryos, Figure 3-3) on the neural side both
within prosensory domain and adjacent to the prosensory domain. This signal could be
interpreted as a neural-to-abneual gradient across the radial axis of the BP. The
expression of the miR-183 family at the prosensory stage has also been observed in the
mouse inner ear. Both miR-183 and miR-182 were broadly expressed in the E9.5 mouse
otocyst, and present in both prosensory tissues and non-sensory domains in the E12.5
mouse cochlea (Sacheli et al., 2009). The reason for the sporadic detection of miR-183
and miR-96 in the prosensory BP could be that their expression levels were
approximately at the detection threshold for in situ hybridization. On the other hand, the
prosensory signal for miR-182 appeared stronger at the base than at the apex (ignoring
the expression in immature hair cells), which could be interpreted as a base-to-apex
longitudinal gradient.
At the apical tip of the BP at S31, HCs on the abneural side start to differentiate with
the appearance of immature stereocilia bundles (Cotanche et al., 1983). The
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differentiation of HCs at the apex in the BP is concomitant with the presence of the miR183 family in the nascent HCs (Figure 3-1, 3-2, 3-3). Whole-mount in situ hybridization
of a S31 BP further confirmed the presence of miR-96 at the apical tip of the BP at this
stage, although the expression of miR-96 was not detected in the basal half (Figure 3-5).
3.3

Expression of the miR-183 family in the basilar papilla at E12-E18

Whole-mount in situ hybridization of the isolated BPs showed the expression of the
miR-183 family in HCs at E12/S38-E18/S44 (Figure 3-6, 3-7, 3-8). Their expression
levels started to decline after S40. At S38-40, there was no apparent expression gradient
along the longitudinal axis of the BP. miR-182 did not show a longitudinal gradient at
even earlier stages S35-S36. At S42-S45, the expression of the miR-183 family showed
an apex-to-base gradient along the longitudinal axis of the BP, which is consistent with
the longitudinal gradient observed in the adult mouse cochlea (Weston et al., 2011).
Section in situ hybridization (Figure 3-10) further confirmed that the longitudinal
gradient observed from the whole mount BPs was also detectable at the single cell level
and did not just result from the higher packing density of the apical HCs.
Although there seemed to be a neural-to-abneural gradient across the radial axis of
the BPs from the surface (Figure 3-6, 3-7, 3-8), section in situ hybridization across the
BPs (Figure 3-9, 3-10) did not reveal qualitative differences in the miRNA expression
level between THCs on the neural side and SHCs on the abneural side. The appearance of
the radial gradient from the whole-mount BPs could come from: (i) differences in cell
packing density on the neural side and on the abneural side across the BP and (ii)
morphology divergence between THCs and SHCs, i.e., THCs have longer cell bodies
than the SHCs.
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Figure 3-5 Expression of miR-96 in the whole-mount basilar papillae at S31 and S38
A: miR-96 is expressed at the apical tip (arrow) of the BP (solid line) at S31. It is also
expressed in the CG neurons (dotted line) underneath the BP. Scale bar equals 0.1 mm. B:
miR-96 is expressed throughout the whole BP at S38. Scale bar equals 0.5 mm.
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Figure 3-6 Expression of miR-183 in the basilar papillae at S38-S45
A-D: low magnification images of the whole BPs. E-H: high magnification images of
THCs. I-L: high magnification images of SHCs. E-L: the regions denoted by the
arrowheads in A-D are shown in high magnification in E-L. A, E, I: S38. B, F, J: S39+. C,
G, K: S41. D, H, L: S45. Scale bar in A-D equals 0.5mm. Scale bar in E-L equals 20µm.
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Figure 3-7 Expression of miR-96 in the basilar papillae at S38+-S44
A-D: low magnification images of the whole BPs. E-H: high magnification images of
THCs. I-L: high magnification images of SHCs. E-L: the regions denoted by the
arrowheads in A-D are shown in high magnification in E-L. A, E, I: S38+. B, F, J: S40-.
C, G, K: S42. D, H, L: S44. Scale bar in A-D equals 0.5mm. Scale bar in E-L equals
20µm.
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Figure 3-8 Expression of miR-182 in the basilar papillae at S38-S45
A-D: low magnification images of the whole BPs. E-H: high magnification images of
THCs. I-L: high magnification images of SHCs. E-L: the regions denoted by the
arrowheads in A-D are shown in high magnification in E-L. A, E, I: S38. B, F, J: S40. C,
G, K: S42. D, H, L: S45. Scale bar in A-D equals 0.5mm. Scale bar in E-L equals 20µm.
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Figure 3-9 Expression of miR-96 in hair cells at S40Cross section through a S40- BP after whole-mount in situ hybridization of miR-96
confirmed that miR-96 was only present in HCs, not in SCs. THCs are located on the
neural side, while SHCs reside on the abneural side. Scale bar equals 20µm.
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Figure 3-10 Section in situ hybridization of miR-182 in the basilar papilla at S43
Top: schematic of the BP. Vertical lines indicate the position of the sections across the
BP. Bottom: section in situ hybridization through the BP. The percentage depicts the
section position from the base from the base (0%) to the apex (100%). At cellular level,
there are no obvious qualitative differences in the miR-182 expression between THCs on
the neural side and SHCs on the abneural side. However, an apex-to-base longitudinal
gradient is apparent. Scale bar equals 50µm.
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CHAPTER 4. MISEXPRESSION OF THE MIR-183 FAMILY IN THE CHICKEN
INNER EAR

4.1

Design of pGFP-183F

In order to elucidate the role of the miR-183 family in HC development and
differentiation, we used an overexpression strategy to introduce ectopic expression of the
miR-183 family. Genomic sequences from the mouse miR-183/96 and miR-182 loci
within an artificial intron (Stoller et al., 2013) were placed downstream of the EGFP
reporter gene in pGFP-183F. The bifunctional expression vector pGFP-183F was
designed to deliver GFP and mature miRNAs simultaneously under the control of
CAGGS promoter (Figure 2-3). Tol2 transposase-mediated transposition was used to
ensure stable transfection (Kawakami, 2007; Sato et al., 2007). Tol2 transposase encoded
by the co-transfected pT2TP vector recognizes Tol2 sites in pGFP-183F and drives a
random integration of the bifunctional cassette flanked by Tol2 sites into the host genome.
During transcription, the microprocessor complex cleaves the intronic pri-miRNA with
three stem-loop structures into pre-miRNAs with single stem-loop structure. The mature
mRNA with GFP open reading frame is then generated by the splicesome. Both the premiRNAs and the GFP mRNA are exported from the nucleus to the cytoplasm, where the
pre-miRNAs are further processed into mature miRNAs and the GFP mRNA is translated
into GFP proteins (Figure 2-3).
4.2

Functional testing of pGFP-183F in vitro

Before in vivo experiments, the functionality of the bifunctional pGFP-183F was
first tested in vitro. It was first tested whether pGFP-183F could produce mature miRNAs
in vitro. HEK293T cells were transfected with pGFP-183F and small RNAs were
collected 30 hours later and probed for each miR-183 family member. Northern blots
showed bands corresponding to the mature miRNAs of the miR-183 family, while the
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Figure 4-1 Functional members of the miR-183 family are produced from pGFP-183F in
vitro
A: Schematic of pT2K-CAG-EGFP-183F. B: Cells transfected with pGFP-183F show
detectable expression of miR-183 family members. Compared to the controls (cells
transfected with pGFP), HEK 293T cells transfected with pGFP-183F display expression
of mature miR-183, -96, and -182. U6 served as the loading control. C: miRNAs
produced from pGFP-183F bind to their complementary targets to decrease luciferase
activity. The miRNA reporters comprised of two complementary miRNA binding sites
(to either miR-183, miR-96, or miR-182) housed downstream of the Renilla luciferase
gene were co-transfected into DF-1 cells with pGFP-183F or pGFP. When pGFP-183F
was included in the transfection, the appropriate miRNA reporter showed a significant
decrease in luminescence compared to control wells (DF-1 cells co-transfected with
pGFP and the appropriate miRNA reporter). D: Reporters respond specifically to their
miRNAs of interest. The luciferase activity of the miR-96 reporter is significantly
decreased when co-transfected with the pGFP-183F vector compared to the control (cells
containing pGFP and the reporter). However, no statistically significant change in
luminescence is seen in cells co-transfected with the reporter and a comparable
expression vector for miR-9 (pGFP-9) compared to the control. Each bar represents mean
(±standard error) for each group. Each experiment was replicated at least three times. ***
p < 0.0001. These data were provided by Michelle L. Stoller.
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Figure 4-2 Staining of DF-1 cells 12 days after transfection
A, B: GFP immunostaining. C, D: Hoechst staining labeling cell nuclei. A, C: DF-1 cells
transfected with pGFP-183F and pT2TP. B, D: DF-1 cells transfected with pGFP and
pT2TP. The molar ratio of pT2TP over either pGFP or pGFP-183F was 0.75:1. The
percentage of GFP+ DF-1 cells transfected with pGFP-183F and pT2TP was 9.88% ±
0.95%, while the percentage after the transfection of pGFP and pT2TP was 14.39% ±
1.02% (p<0.01).
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miRNA bands were not detected in cells transfected with the control plasmid pGFP. The
bioactivity of the miRNAs expressed by pGFP-183F was further tested in chicken cells
via a dual luciferase assay. Luciferase reporters were constructed with two binding sites
complementary to one member of the miR-183 family in the 3’UTR of the gene encoding
renilla luciferase in psiCheck-2 (Stoller et al., 2013). The reporters also encoded firefly
luciferase, which worked as a transfection control. When co-transfected into DF-1 cells
with pGFP-183F, the luminescence ratio of renilla luciferase luminescence over firefly
luciferase luminescence was significantly reduced by at lease 82%, indicating that the
mature miRNAs produced by pGFP-183F was functional in chicken cells. I built the
luciferase reporter for miR-96. The luciferase reporters for miR-183 and miR-182 were
built by Michelle L. Stoller (Stoller et al., 2013). She also performed the northern blots
and the luciferase assays described above and shown in Figure 4-1 B-D.
In order to confirm the stable integration of the sequence flanked by Tol2 sites
triggered by Tol2 transposase, DF-1 cells were cultured for 12 days after co-transfection
of pT2TP and either pGFP or pGFP-183F before GFP immunostaining and cell nuclei
staining. The transfection was performed at 4 different molar ratios of pT2TP to
pGFP/pGFP-183F: 0, 0.375, 0.75 and 1.5. While almost no GFP+ DF-1 cells were found
12 days after transfection with pGFP/pGFP-183F only, the GFP+ percentage was slightly
higher after the transfection at a molar ratio of 0.75 than 0.375 and 1.5. The percentage of
GFP+ DF-1 cells 12 days after the transfection of pGFP-183F and pT2TP at a molar ratio
of 0.75 was 9.88% ± 0.95%, while the percentage after the transfection of pGFP and
pT2TP at the same molar ratio was significantly higher (14.39% ± 1.02%, p<0.01).
Furthermore, the GFP staining was brighter in pGFP-transfected cells compared to pGFP183F-transfected cells (Figure 4-2). Taken together, it suggested that the insertion of the
artificial intron in pGFP-183F might affect the transfection efficiency, the integration of
the bifunctional cassette into the host genome, or the expression of GFP proteins.
4.3

Misexpression of the miR-183 family in vivo

Since the bifunctional cassette in pGFP-183F could produce both GFP proteins and
functional members of the miR-183 family in vitro, pGFP-183F and pT2TP were injected
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and then electroporated into the right otic cups (S11-12) or otocysts (S14-S17) of chicken
embryos. The ectopic expression of the miR-183 family was observed as early as S26
(Figure 4-3), before the majority of sensory progenitors in the BP exit the cell cycle
(Katayama et al., 1989). Ectopic miRNA signal was observed in the SE, non-SE and the
VG and CG at S31 (Figure 4-4). In situ hybridization and GFP immunostaining of
adjacent sections confirmed that the regions showing ectopic miRNA expression colocalized with GFP (Figure 4-4).
The overexpression of miR-183 family persisted for two weeks after electroporation
of pGFP-183F and pT2TP. Compared with control left BPs, pGFP-183F-transfected BPs
showed ectopic expression of the miR-183 family members in SCs and non-sensory
epithelial cells at S40 (Figure 4-5, 4-6). The neurofilament patterning labeled by 3A10
was comparable between control BPs and pGFP-183F transfected BPs (Figure 4-5),
despite the ectopic expression of the miR-183 family in the CG neurons (Figure 4-4).
Although many HCs in immunostained whole-mount BPs were obviously GFP+, we
were unable to confirm that the miR-183 family levels exceeded endogenous levels in
HCs by whole-mount in situ hybridization (Figure 4-5, 4-6) or subsequent sectioning of
whole mounts (Figure 4-5).
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Figure 4-3 Ectopic expression of miR-96 two days after electroporation
Sections through the inner ear of a S26 embryo, following electroporation of the right ear
with pGFP-183F and pT2TP at S15, are shown. A-C: horizontal sections through the AC.
D-F: sections through the cochlear duct. A, D: the control left ear. B, C, E, F: the right ear
transfected with pGFP-183F and pT2TP. A, B, D, E: miR-96 in situ hybridization. C, F:
GFP immunostaining. At S26, miR-96 was weakly expressed in the vestibular organs and
the VG, but was absent in the BP. The electroporated ear showed ectopic expression of
miR-96 in the epithelia (arrows in B, E) that corresponded to GFP immunolabeling in
adjacent sections (arrows in C, F). Scale bar equals 100 µm.
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Figure 4-4 Ectopic expression of miR-182 and miR-96 four days after electroporation
Horizontal sections through the inner ear of a S31 embryo, following electroporation of
pGFP-183F and pT2TP at S17, are shown. A-G: adjacent sections through the vestibular
organs. H-M: adjacent sections through the cochlear duct. A, D, F, H, K: the control left
ear. B, C, E, G, I, J, L, M: the electroporated right ear. A, B, H, I: miR-182 in situ
hybridization. D, E, K, L: miR-96 in situ hybridization. C, J: GFP immunostaining. F, G,
M: HCS-1 staining. There was ectopic expression of miR-182 and miR-96 in the sensory
and non-SE and also in the VG and CG neurons in B, E, I and L. The ectopic expression
co-localized with GFP staining depicted in C and J. However, there were no ectopic HCs
observed in transfected non-SE labeled by HCS-1 in G and M (arrows) compared to F
and K. Of note, although there were a few HCS-1+ cells in the mesenchyme in both F
and G, similar staining was also seen in the inner ear of wildtype embryos. Scale bar
equals 100µm.
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Figure 4-5 Ectopic expression of miR-182 in the cochlear duct 12 days after
electroporation
A, B, E, F: whole-mount BPs of miR-182 in situ hybridization. C, D, G, H: sections
labeled with miR-182 in purple and neurofilament marker 3A10 in brown. A, C, E, G:
control left BPs. B, D, F, H: right BPs that were electroporated at S14 (B, D) and at S16
(F, H). There was ectopic expression of miR-182 in the SE and non-SE in the wholemount BPs in B and F. Subsequent sectioning of whole-mount BPs showed ectopic miR182 in the SCs and also in the non-SE in D and H. The neurofilament patterning was
comparable between C and D and between G and H. Scale bar in A equals 0.5 mm. Scale
bars in C and G equal 50 µm.
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Figure 4-6 Ectopic expression of the miR-183 family in the basilar papillae at S40
A-C: low magnification images of whole-mount BPs. D-I: high magnification images. A:
control left BP. B-I: right BPs electroporated with pGFP-183F and pT2TP at S11+ (B-E),
S12 (F, G) and S14 (H, I). C: GFP fluorescence before in situ hybridization. D, F, H:
images taken at the HC layer. E, G, I: images taken at the SC layer. Arrows in B and C
point to examples where GFP+ cells overlap with a higher signal intensity of miR-183.
The non-SE that were GFP+ in C (arrowheads) were removed before in situ hybridization,
thus ectopic miR-183 expression in these cells was not observed in B. There were patches
of overexpression for all the three family members in the S40 BPs transfected with
pGFP-183F and pT2TP. Scale bar in A equals 0.5 mm. Scale bar in D equals 100 µm.
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4.4

Misexpression of the miR-183 family did not alter hair cell subtypes

The miR-183 family is expressed with an apex-to-base gradient along the
longitudinal axis of the BP at S42-S45. Along the BP, HCs at the apex have smaller
lumenal surface areas, longer cell bodies, and longer and narrower stereocilia bundles
compared to HCs at the base. To answer the question whether disturbance of the
longitudinal gradient of the miR-183 family could affect the specification of HC subtypes
along the BP, pGFP-183F-transfected BPs were stained with anti-GFP to identify
transfected cells, HCS-1 to measure HC cross-section areas and phalloidin to label HC
bundles. The presence of GFP immunolabeling was used as an indirect indicator of
ectopic miRNA expression. Because the level of the miR-183 family was higher in the
apical HCs than the basal HCs, the prediction was that basal HCs with overexpression of
the miR-183 family would acquire the characteristics of apical HCs. However, no
morphological differences between GFP+ HCs and their neighboring GFP- HCs were
found at the base (Figure 4-7). Their maximum cross-section areas were not significantly
different.
A neural-to-abneural gradient of the miR-183 family across the prosensory region in
the BP is observed at S31. We speculated that the miR-183 family might be involved in
the determination of neural versus abneural identity of the prosensory cells. It was
predicted that HCs on the abneural half of the BP could acquire the characteristics of
THCs after overexpression of the miR-183 family, instead of becoming SHCs. In order to
test this idea, pGFP-183F-transfected BPs were stained with anti-Ctbp2 to label ribbon
synapses, anti-GFP and HCS-1. THCs have more ribbon synapses than SHCs, as they are
innervated by the majority of afferent nerve fibers. However, there were no significant
differences in the number of ribbon synapses between GFP+ SHCs and their neighboring
GFP- SHCs at the base (Figure 4-8). In conclusion, misexpression of the miR-183 family
did not alter HC subtypes along the longitudinal axis and across the radial axis of the BPs.
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Figure 4-7 Misexpression of the miR-183 family did not alter hair cell subtypes along the
basilar papillae
A-D: A S40- BP electroporated with pGFP-183F and pT2TP at S11 was stained with
anti-GFP, phalloidin and HCS-1. A, B: images taken at the base. C, D: images taken at
the apex. A, C: images at the layer of HC nuclei. B, D: images at the layer of stereocilia
bundles. In A and C, the green round-shaped areas were GFP+ HCs, in which the
cytoplasm was also HCS-1+. The green triangle-shaped areas or the green lines were the
apical surfaces of GFP+ SCs. Compared to apical GFP- HCs, basal GFP- HCs had bigger
cross-section areas and wider stereocilia bundles. However, GFP+ HCs at the base had
similar cross-section areas and similar width of stereocilia bundles compared with their
neighboring GFP- HCs, indicating that they did not acquire the characteristics of apical
HCs. Scale bar in A equals 20µm. Boxed areas were shown with high magnification. E:
Quantification of maximum cross-section areas of GFP- HCs versus GFP+ HCs at the
base of five pGFP-183F-transfected BPs. Tukey box and whiskers were shown in the
diagram, with the box extending from 25 percentile to 75 percentile, the line in the
middle of the box at the median and outliers shown in dots. Two-way ANOVA analysis
showed no significant differences between GFP- HCs and GFP+ HCs. Sample stage:
300-13, S40-; 300-12, S39; 301-1, S38; 301-3, S38; 301-8, S38.
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Figure 4-8 Misexpression of the miR-183 family did not alter hair cell subtypes across
the basilar papillae
A-D: A S40- BP BP transfected with pGFP-183F and pT2TP at S15 was stained with
anti-GFP, anti-Ctbp2 that labels ribbon synapses and HCS-1. A: anti-GFP. B: anti-Ctbp2.
C: HCS-1. D: merged image. Maximum intensity projections of the image stack at the
base of the BP were shown with neural on top. GFP- THCs on the neural side had more
ribbon synapses than GFP- SHCs on the abneural side. GFP+ SHCs had similar number
of ribbon synapses compared with their neighboring GFP- SHCs. Scale bar in A equals
20µm. Boxed areas were shown with high magnification. E: Numbers of ribbon synapses
in GFP- SHCs, GFP+ SHCs, GFP- THCs and GFP+ THCs from the base of five pGFP183F-transfected BPs were compared (mean ± SEM). The number of ribbon synapses in
GFP+ SHCs and GFP- SHCs were not significantly different by two-way ANOVA
analysis. ND stands for not determined due to sparse GFP staining in THCs. Sample
stage: 272-21, S39+; 271-10, S40; 271-15, S40; 2691-1, S40; 269-9, S40-.
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4.5

Ectopic hair cells in non-sensory epithelia did not correlate with overexpression of
the miR-183 family
In the zebrafish inner ear, overexpression of miR-96 or miR-182 could induce

ectopic sensory patches and extra HCs at 26hpf (Li et al., 2010b). Therefore, we posited
that overexpression of the miR-183 family might also generate ectopic sensory patches in
non-SE in chicken inner ear. At S26-32, no ectopic HC patches labeled by anti-otoferlin
(HCS-1) were found outside of normal sensory patches in pGFP-183F-electroporated ears
(n=4, Figure 4-4). At S38-S41, 91% of the right BPs transfected with pGFP-183F (n =
30/33) did not have ectopic HCs (Figure 4-9). However, five ectopic HCS-1+ sensory
patches were observed in the non-SE beyond the normal boundaries of the BP from 3
embryos. These ectopic patches had various sizes and were located on different positions.
However, their existence was not correlated with pGFP-183F transfection, as three of the
ectopic patches were GFP-. One left control BP had a patch of 4 HCs (70% from the base
on the superior side), while the right transfected BP from the same embryo had two GFPectopic patches (24 HCs at 70% from the base on the superior side and about 300 HCs at
90% from the base on the inferior side). There were two GFP+ ectopic patches, of which
one had 65 HCs located at 90% from the base on the inferior side and the other had 9
HCs located at 30% from the base on the superior side. Therefore, overexpression of the
miR-183 family did not increase the probability of the ectopic sensory patches, based on
the assumption that GFP and the miR-183 family members were co-expressed in all the
pGFP-183F-transfected cells. We speculated that the ectopic sensory patches might result
from the electroporation procedure, because we never found ectopic sensory patches in
wildtype embryos.
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Figure 4-9 Misexpression of the miR-183 family did not generate ectopic hair cells in
non-sensory epithelia
A S38 BP electroporated with pGFP-183F and pT2TP at S11- was immunostained with
anti-GFP and HCS-1. HCS-1 staining labeled HCs in the BP and the LM. HCS-1+ cells
were not found in the homogene (Hm) and hyaline (Hy) cells in B, although they were
GFP+ in A. Scale bar equals 100 µm.
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4.6

Misexpression of the miR-183 family biased progenitor cells toward a hair cell fate
Since the ectopic expression of the miR-183 family was detected as early as S26 in

the prosensory cells in the BP, before the majority of the cells come out from cell
division, the next question was whether misexpression of the miR-183 family could bias
bipotential progenitor cells toward a HC fate rather than a SC fate. The number of GFP+
HCs and GFP+ SCs were counted in S38-S40 BPs transfected with either pGFP or pGFP183F and stained with anti-GFP, HCS-1 and anti-Sox2 that labels SC nuclei or nuclei dye
TO-PRO-3. The ratio of GFP+ SCs/GFP+ HCs was calculated. The prediction was that
misexpression of the miR-183 family would generate more HCs at the expense of SCs,
thus pGFP-183F-transfected BPs would have a lower ratio of GFP+ SCs/GFP+ HCs than
pGFP-transfected BPs. In fact, the ratio in the middle and apical areas was lower in
pGFP-183F-transfected BPs. However, the decrease was only statistically significant (p <
0.05, one-tailed t-test) in the middle region along the BP (Figure 4-10, Table 4-1). It is
noteworthy that there are strong GFP+ and weak GFP+ HCs and strong GFP+ and weak
GFP+ SCs in both pGFP and pGFP-183F-electroporated BPs.
We also wanted to know whether misexpression of the miR-183 family in SCs could
lead to a mixed HC-SC phenotype. However, GFP+ and Sox2+ cells were never colabeled by HCS-1 (Figure 4-10).
Weston and colleagues identified murine Sox2 as a miR-182 target by luciferase
assay in vitro (Weston et al., 2011), although I found that human Sox2 3’UTR was not
recognized as a miR-182 target (Figure 5-1). Chicken Sox2 did not have binding sites for
any of the miR-183 family members according to the miRNA target predictions in
TargetScan (v6.2). Nonetheless, I was curious to know whether overexpression of the
miR-183 family in SCs downregulated the level of Sox2 protein, which might lead to the
increase in HC number. However, there was no qualitative difference in Sox2
immunolabeling in GFP+ SCs compared to their neighboring GFP- SCs in pGFP-183Ftransfected BPs (Figure 4-10).
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Figure 4-10 Misexpression of the miR-183 family biased progenitor cells towards a hair
cell fate
A-H: A S38 BP electroporated with pGFP-183F and pT2TP at S11- was stained with
anti-GFP, HCS-1 and anti-Sox2. A-D: images through the HC layer. E-H: images
through the SC layer. Of note, co-localization of Sox2 and HCS-1 was not present. The
intensity of Sox2 immunolabeling in GFP+ SCs (arrows in E-H) was similar to GFP- SCs.
Scale bar in D equals 20 µm. Boxed areas were shown with high magnification. I: the
numbers of GFP+ SCs and GFP+ HCs were counted at the base, the middle and the apex
in pGFP-183F-transfected BPs (n=9) and pGFP-transfected BPs (n=8). The ratio of
GFP+ SCs/GFP+ HCs was calculated and compared (mean ± SEM). The ratio was
significantly different at the middle along the BPs when comparing pGFP-183F and
pGFP transfected BPs (p < 0.05, one-tailed t-test). Two-way ANOVA showed that the
ratio was significantly affected by the positions along the BPs.
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Table 4-1 Ratio of GFP+ supporting cells to GFP+ hair cells
Base 25%
Sample

Stage

GFP+
SCs

pGFP and pT2TP
307-2
39
472
307-9
38
174
307-16
38
432
317-6
39+
485
317-11
39+
433
317-12
38
406
319-1
39
705
319-9
39
586
Mean
SEM
pGFP-183F and pT2TP
304-11
38
325
306-18
40387
308-11
38
302
310-7
38
415
310-12
39
260
311-1
40170
312-7
39
232
312-9
37
386
312-11
38
344
Mean
SEM
One-tailed t-test
Two-way ANOVA
SS
(repeated measures)
Interaction
2.352
Location
9.658
Treatment
1.487
Subjects (matching) 15.42
Residual

9.075

Middle 50%
GFP
GFP+
+
HCs
SCs

Apex 75%

GFP+
HCs

SC/
HC

157
123
161
238
255
208
170
201

3.01
1.41
2.68
2.04
1.70
1.95
4.15
2.92
2.48
0.31

553
327
616
479
469
770
621
465

130
158
73
245
75
45
100
192
154

2.50
2.45
4.14
1.69
3.47
3.78
2.32
2.01
2.23
2.73
0.30
0.28

516
316
234
451
294
132
181
317
524

DF

MS

F (DFn, DFd)

P value

2
2
1
15

1.176
4.829
1.487
1.028
0.302
5

F (2, 30) = 3.888
F (2, 30) = 15.96
F (1, 15) = 1.447
F (15, 30) = 3.398

P = 0.0315
P < 0.0001
P = 0.2477
P = 0.0021

30

SC/
HC

GFP+
SCs

GFP+
HCs

SC/
HC

161
231
158
227
205
345
196
271

3.43
1.42
3.90
2.11
2.29
2.23
3.17
1.72
2.53
0.31

850
363
654
582
409
1039
355
288

338
202
208
394
450
495
239
293

2.51
1.80
3.14
1.48
0.91
2.10
1.49
0.98
1.80
0.27

226
182
120
281
197
54
123
269
289

2.28
1.74
1.95
1.60
1.49
2.44
1.47
1.18
1.81
1.77
0.13
0.02

574
267
391
436
300
172
212
374
356

310
190
156
431
365
160
189
455
374

1.85
1.41
2.51
1.01
0.82
1.08
1.12
0.82
0.95
1.29
0.18
0.07

*
****
ns
**
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CHAPTER 5. TARGET VERIFICATION OF MIR-182

5.1

Validated human targets of miR-182

Target prediction and verification are necessary in order to understand downstream
mechanisms of specific miRNAs. Because knockdown and misexpression of miR-182
lead to opposite effects on the number of HCs in zebrafish inner ear, Haiqiong Li decided
to first verify target genes for miR-182. She generated a list of 20 human genes (Table 51) by target-prediction algorithms (TargetScan, MicroCosm, Diana Micro-T and PicTar)
and known gene expression in the inner ear. Commercially built pSGG_3UTR luciferase
reporters containing firefly luciferase and the 3’UTR of the 20 human genes were
purchased from SwitchGear Genomics, together with two negative control reporters
containing empty 3’UTR (Empty) or random 3’UTR (R01) (Figure 5-1). pSGG_3UTR
and a renilla luciferase plasmid pRL-SV40 that worked as a transfection control were
transfected into HEK293T cells, along with miRIDIAN double-stranded miRNA mimics
(miR-182 or negative control #1). The cells were lysed 24 hours post transfection and the
luminescence from firefly and renilla luciferases was measured by Dual-luciferase
reporter assay. The luminescence from firefly luciferase was normalized by renilla
luciferase luminescence to eliminate the effects of different transfection efficiencies. The
relative luciferase activity was calculated by dividing normalized firefly luminescence
values in the presence of miR-182 mimics by the values in the presence of negative
control #1 miRNA mimics. The relative luciferase activity of the 20 human 3’UTR
reporters was compared with the random 3’UTR R01 and 14 of them were significantly
different (p < 0.05, t-test), indicating that miR-182 could bind with their 3’UTRs and
downregulate the expression of firefly luciferase (Figure 5-1, Table 5-1).
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I also wanted to know which of the target-prediction algorithms did a better job in
predicting the miRNA targets considering the relative luciferase activity we obtained.
Linear regression analysis of the relative luciferase activity shown as a function of PicTar
and TargetScan prediction scores came up with modest correlation coefficients (R2 =
0.5961 for TargetScan v5.1 and 0.5851 for PicTar) (Figure 5-1). Interestingly, when I
analyzed the relative luciferase activity as a function of prediction scores in the most
recent version of TargetScan v6.2, the correlation coefficient R2 increased to 0.7649.
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Figure 5-1 Luciferase assays for validating potential targets of miR-182
A: Plasmids for in vitro luciferase assays. Human 3’UTRs were placed downstream of
the coding region for destabilized Firefly luciferase (purchased from SwitchGear
Genomics), and these test plasmids were then co-transfected with Renilla luciferase
plasmids into HEK293T cells, along with double-stranded miRNA mimics (Thermo
Scientific Dharmacon). B: Relative luciferase activity. At 24 hours post transfection,
luminescence originating from Renilla protein was used to normalize the transfection
efficiency in each well of a 96-well plate using the Dual-Glo Luciferase Assay System
(Promega). Then, the luminescence from Firefly luciferase in the presence of miRIDIAN
ds miRNA-182 mimic was compared with that obtained in the presence of a miRIDIAN
ds-miRNA mimic negative control #1 (5’-UCACAACCUCCUAGAAAGAGUAGA-3’)
provided by the manufacturer. Values are shown as means plus standard errors from at
least six replicates performed over at least two independent experiments. White bars are
negative controls. Dark bars are constructs with luminescence ratios below 0.70 (dashed
line); in this group the knockdowns by miR-182 are statistically significant in comparison
with a plasmid carrying the R01 3’UTR that has no predicted binding sites for miR-182
(t-test, p < 0.05). Gray bars are constructs that were not significantly different from R01.
C: Relative luciferase activity shown as a function of target prediction scores for PicTar
and TargetScan. Note that each program outputs a score for only a subset of the 20 tested
3’UTRs. Linear regression analysis of the data gives modest correlation coefficients for
TargetScan (R2 = 0.5961) and PicTar (R2 = 0.5851).
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A

3’ UTRs

pro

Firefly luciferase (luc2-PEST)

pA

pSGG-3UTR (SwitchGear Genomics)
pSV40

pA

pRL-SV40 (Promega)
1.2
1.0
0.8
0.70

0.6
0.4

Relative Luciferase Activity
(+ds-mR-182/+ds-miR control)

C
1.2

PicTar

BDNF
ISL1
LHX3
PAIP2
PGR
SOX2

ACTR2
CREB3L1
EPAS1
FOXF2
MET
MYO1C
MYRIP
NCALD
PCDH8
RAB3GAP2
RASA1
RGS17
RNF212
SLC35A5

0.2
Empty
R01

Relative Luciferase Activity
(+ds-mR-182/+ds-miR control)

B

Renilla luciferase

Targetscan

1.0
0.8

0.70

0.6
0.4

MYO1C

MYO1C

0.2
1

3

5
Score

7

9 -0.1 -0.3 -0.5 -0.7 -0.9 -1.1
Total Context Score
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Table 5-1 Potential targets of miR-182 tested in luciferase assay

Human
gene

Gene name

3’UTR that is targeted by miR-182
ARP2 actin-related protein 2
ACTR2
homolog (yeast)
CREB3L cAMP responsive element
1
binding protein 3-like 1
endothelial PAS domain protein
EPAS1
1
FOXF2
forkhead box F2
met proto-oncogene (hepatocyte
MET
growth factor receptor)
MYO1C
Myosin 1C
myosin VIIA and Rab
MYRIP
interacting protein
NCALD
neurocalcin delta
PCDH8
protocadherin 8
RAB3GA RAB3 GTPase activating
P2
protein subunit 2 (non-catalytic)
RAS p21 protein activator
RASA1
(GTPase activating protein) 1
regulator of G-protein signaling
RGS17
17
RNF212
ring finger protein 212
SLC35A solute carrier family 35,
5
member A5
3’UTR that is not targeted by miR-182
Brain-derived neurotrophic
BDNF
factor
Insulin gene enhancer protein
ISL1
ISL-1
LHX3
LIM/homeobox protein Lhx3
poly(A) binding protein
PAIP2
interacting protein 2
PGR
progesterone receptor
SRY (sex determining region
SOX2
Y)-box 2

Relat
ive
lucife
rase
activi
ty

Conse
rved
sites

Poorl
y
conse
rved
sites

Target
Scan
v5.1

Target
Scan
v6.2

0.521

1

3

-0.91

-0.59

0.284

2

0

-0.69

-0.53

0.474

1

1

-0.80

-0.56

4.26

0.363

1

1

-0.66

-0.54

7.30

0.566

1

2

0.424

2

0

-0.19

-0.30

3.13

0.429

2

1

-0.79

-0.51

4.90

0.617
0.406

1
2

2
0

-0.88
-0.63

-0.54
-0.46

4.93
8.37

0.591

2

0

-0.64

-0.32

0.458

2

0

-0.68

-0.53

0.139

1

2

-1.12

-0.81

0.881

1

0

-0.17

-0.12

1.55

0.982

1

0

-0.21

-0.14

2.56

0.905

1

0

-0.20

-0.16

3.11

0.757

1

0

-0.43

-0.33

2.77

1

0

-0.27

-0.18

2.68

Pic
Tar

-0.48

6.95

0.647
0.434

0.932
0.918
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CHAPTER 6. CONCLUSION AND DISCUSSION

6.1

Conclusion

In this study, I showed temporal and spatial expression of the miR-183 family in the
developing avian inner ear (CHAPTER 3). The three miRNAs shared a similar
expression pattern with high expression in HCs and the CVG neurons. They briefly
showed a neural-to-abneural gradient in the prosensory BP at E7 and later displayed an
apex-to-base gradient along the BP at E16-18. To figure out a possible role of the miR183 family in establishing or maintaining HC phenotypic gradients, they were
overexpressed in the chicken inner ear prior to and during HC differentiation (CHAPTER
4). However, no obvious changes were observed in HC morphologies either along or
across the BP. Although misexpression of the miR-183 family did not induce ectopic
HCs in non-SE, I found that there was a slight bias towards a HC fate rather than a SC
fate at the middle region along the BP. In addition to exploring expression and
misexpression of the miR-183 family in vivo, I also verified 14 human gene targets of
miR-182 by in vitro luciferase assay (CHAPTER 5).
6.2
6.2.1

Discussion

The miR-183 family was transiently expressed in the prosensory region of the
basilar papillae

The miR-183 family presented a faint expression on the neural side of the
prosensory domain and adjacent to the prosensory domain in the basal half of the BPs at
E7. The miR-183 family was not detected in the cochlear duct at earlier time points S2628, but was transiently found in the postmitotic prosensory cells at S31, implying that the
miR-183 family might be involved in the differentiation of the prosensory cells into HCs
or SCs, but not in the maintenance of prosensory cell fate. It has also been reported in the
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mouse cochlea that the miR-183 family was expressed in the prosensory domain before
the differentiation of HCs and SCs at E15.5 (Sacheli et al., 2009). In the middle part of
the cochlear duct at E15.5, the miR-183 family was detected in the majority of cochlear
duct cells with stronger expression in SE and GER adjacent to the neural side of the SE.
However, in zebrafish inner ear the miR-183 family was not detected in prosensory cells,
but was only found in HCs (Li, 2010).
BMP4 in the BP at E6.5-E9 had a stronger expression in the neural region than the
abneural region in the SE, despite its expression in the non-SE next to the abneural
sensory region (Oh et al., 1996). A recent study showed that TGF-β induced the
expression of miR-183 in natural killer cells to inhibit their function of tumor cytolysis
(Donatelli et al., 2014). This raises a possibility that BMP4 might be involved in the
regulation of the miR-183 family expression in the prosensory cells in the basilar papilla,
which needs further investigation.
The non-SE adjacent to the neural side of the prosensory domain are composed of
homogene cells. One Wnt ligand, Wnt9a, was expressed in homogene cells at S27
(Sienknecht et al., 2008; Sienknecht et al., 2009) and might play a role in the patterning
of the radial axis of the BP. One RA synthesis enzyme, Raldh3, was also shown to be
expressed in the homogene cells, but at a later stage S34 (Sanchez-Guardado et al., 2009).
6.2.2 Up-regulation of the miR-183 family was linked to the initiation of hair cell
differentiation in the basilar papilla
At S31, the miR-183 family was detected in the immature HCs on the abneural side
at the apex of the BP. The intensity of the signal level was obviously stronger in the
immature HCs than in the prosensory cells at the base, suggesting that the miRNAs were
up-regulated after HC differentiation.
HC differentiation started at the distal tip of the BP, which has been reported in
several studies. The stereocilia bundles were first observed at the apex at S32 by scanning
electron microscopy (Cotanche et al., 1983). Immunohistochemistry studies indicated that
HC differentiation started as early as S29 in the BP. Immature HCs labeled by class III β-
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tubulin could be identified in the distal BP at S29 (Molea et al., 1999). HCA
immunostaining (anti-PTPRQ) in the stereocilia could be observed at the apex at S29
(Bartolami et al., 1991; Goodyear et al., 1997; Goodyear et al., 1995), but only on the
posterior longitudinal sections corresponding to the abneural side (Bartolami et al., 1991).
Another HC marker HCS-1 (anti-otoferlin) was not observed in the BP until E7 in
immature HCs on the abneural side (Goodyear et al., 2010).
Furthermore, there are some other genes that were differentially expressed across the
BP at E7. For example, Jagged1/Serrate1, one Notch ligand involved in lateral induction,
was expressed on the neural side of the BP, while Hes5, one downstream target of Notchmediated lateral inhibition, was detected on the abneural side (Petrovic et al., 2014). One
possible explanation of this differential expression is that the prosensory cells on the
abneural side of the BP may differentiate earlier than the neural side, since lateral
inhibition underlying the salt-and-pepper patterning of HCs and SCs happens after lateral
induction involved in prosensory specification.
6.2.3

The longitudinal gradient of the miR-183 family might establish expression
gradients of some target genes

The longitudinal gradient of the miR-183 family along the BP was presented as
higher expression in apical HCs than in basal HCs at S42-S45, which is consistent with
the gradient along the cochlea in the adult mouse (Weston et al., 2011). This longitudinal
gradient was in support of the finding that predicted gene targets of miR-182 and miR-96
were enriched in the base of the BPs at P0 by microarray analysis (Frucht et al., 2011).
Table 6-1 lists some chicken genes that were enriched at the base versus the apex at P0
with conserved binding sites for the miR-183 family.
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Table 6-1 Predicted chicken targets of the miR-183 family that are significantly enriched
at the base at P0
Chicken gene
gga-miR-183
DUSP10
EML4
ENAH
PKP4
PPP2CA
PSEN2
STK38L
TCF12
TPM1
ZDHHC6
gga-miR-96
BRWD1
COBL
EPB41L3
ITPR2
LRCH2
MITF
PLCB4
SDC2
TPM1
ZFAND5

Gene name

dual specificity phosphatase 10
echinoderm microtubule associated
protein like 4
enabled homolog (Drosophila)
plakophilin 4
Protein phosphatase 2 (formerly 2A),
catalytic subunit, alpha isoform
presenilin 2 (Alzheimer disease 4)
serine/threonine kinase 38 like
transcription factor 12 (HTF4, helixloop-helix transcription factors 4)
tropomyosin 1 (alpha)
zinc finger, CCHC domain containing 6
bromodomain and WD repeat domain
containing 1
cordon-bleu homolog (mouse)
erythrocyte membrane protein band
4.1-like 3
inositol 1,4,5-triphosphate receptor,
type 2
leucine-rich repeats and calponin
homology (CH) domain containing 2
microphthalmia-associated transcription
factor
phospholipase C, beta 4
syndecan 2
tropomyosin 1 (alpha)
zinc finger, AN1-type domain 5

Conserved
miRNA sites

Base/Apex
(Frucht et al.,
2011)

1

2.04

1

2.72

1
1

5.87
2.07

1

2.21

1
1

2.11
6.74

2.97

2

10.15

2.17

1
1

3.74
2.80

2

3.57

1

13.34

1

2.70

1

4.72

2

2.12

1

3.74

1
1
1
1

3.26
3.98
3.74
2.20

6.25

2.09

6.29

The number of conserved gga-miR-183 sites is obtained when searching for targets of
chicken miR-183 in TargetScan v6.2. The conserved gga-miR-96 or 182 sites are sites
conserved between human and chicken when searching for targets of human miR-96 or
182. Some genes had two base/apex ratios detected by two different probes in the
microarray hybridization (Frucht et al., 2011).
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Table 6-1 Continued
Chicken gene
gga-miR-182
AEBP2
CUL5
EPHA7
MITF
PAFAH1B1
RASA1
RET
SLC4A7
VLDLR

Gene name

AE binding protein 2
cullin 5
EPH receptor A7
microphthalmia-associated transcription
factor
platelet-activating factor acetylhydrolase,
isoform Ib, alpha subunit 45kDa
RAS p21 protein activator (GTPase
activating protein) 1
ret proto-oncogene
solute carrier family 4, sodium bicarbonate
cotransporter, member 7
very low density lipoprotein receptor

Conserved
miRNA sites

Base/Apex
(Frucht et al.,
2011)

1
1
1

5.30
7.91
7.61

1

3.74

1

2.08

2

2.24

1

8.00

1

3.24

1

5.08

6.22

BOLD font indicates genes expressed in cochlear HCs (GFP+) at greater than 50 reads at
P0, P4 and/or P7 in Pou4f3-GFP mice. Italics font indicates genes repressed at least 30%
in P0 cochlear HCs (GFP+) vs. other cochlear cells (GFP-) in Pou4f3-GFP mice (the
repression ratio was only checked for genes in bold font; Shared Harvard Inner-Ear
Laboratory Database: https://shield.hms.harvard.edu/index.html).
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Weston and colleagues proposed that the miR-183 family might play a role in
establishing expression gradients of other genes. However, they found that miRNA
depletion in the HCs in Atoh1-Cre; Dicer1 CKO mouse resulted in an increasing number
of genes (231 in control and 999 in CKO mice) that had at least 2-fold expression
differences between basal and apical organ of Corti at P16 by microarray analysis
(Weston et al., 2011). This demonstrated that miRNAs in the HCs appear to suppress
longitudinal gradients, instead of promoting the gradients. However, this could not rule
out the possibility that the miR-183 family could underlie expression gradients of some
targets in the organ of Corti. Furthermore, the microarray analysis was based on mRNA
levels, while both mRNA decay and translational repression could happen in miRNAmediated post-transcriptional regulation.
6.2.4

Technical caveats related to misexpression of the miR-183 family

Delivery of the miR-183 family expression vector into the chicken inner ear at
E2/E3 failed to alter HC phenotypes either along the longitudinal axis or across the radial
axis of the BP 11-14 days later. There are several technical caveats that might explain this
failure. One possibility is that the phenotypic changes could not be observed until an
older age. The longitudinal gradient of the miR-183 family in the wildtype BP was only
observed after S42. But due to low survival rate and a developmental delay after
electroporation, most of the sacrificed embryos were staged as ~S40.
Luciferase assay and Northern blot in vitro showed that functional mature miRNAs
could be generated after transfection of the pGFP-183F vector, and in situ hybridization
in vivo revealed that ectopic miRNAs were produced in SCs and non-sensory epithelial
cells. Nevertheless, I did not see clear evidence for miRNA overexpression in HCs,
because it was hard to distinguish HCs from the apical processes of the transfected
surrounding SCs in in situ hybridization and also because of strong endogenous HC
expression. One possibility is that the miR-183 family could not be persistently
overexpressed in the transfected HCs, although immunohistochemistry clearly revealed
that GFP was expressed in the transfected HCs after delivery of the bifunctional vector
pGFP-183F. One possible explanation could be that the miRNA levels are tightly
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regulated in HCs, like in the mouse retina the concentration of the miR-183 family was
about 1-fold higher during light adaption than dark adaptation (Krol et al., 2010). There
may be an unknown regulatory pathway in HCs regulating the precise level of the miR183 family, in other words, suppressing the miRNA biogenesis or triggering the miRNA
decay when their levels are artificially increased. An alternate explanation could be due
to a limited capacity of miRNA biogenesis machinery in the HCs.
Another possibility is that the overexpression of the miR-183 family was present in
HCs, but could not sufficiently downregulate their targets to produce downstream effects.
miRNAs only modulate the levels of their targets, rather than switch on/off the protein
expression (Baek et al., 2008; Selbach et al., 2008).
6.2.5 Progenitor cells were biased toward a hair cell fate after misexpression of the
miR-183 family
Despite the observation of a few ectopic HCs in the non-SE after pGFP-183F
electroporation, their presence was not correlated with the expression of GFP, but might
come from some isolated cell patches after the electroporation process. This
demonstrated that the expression of miR-183 family in non-sensory epithelial cells was
not sufficient to induce a sensory cell fate in the chicken inner ear. The ectopic
expression of the miR-183 family in SCs illustrated that its ectopic expression in sensory
precursors was not sufficient to lead to their acquisition of a HC fate. Nevertheless, I
found that overexpression of the miR-183 family decreased the ratio of GFP+ SCs/GFP+
HCs when comparing between pGFP and pGFP-183F transfected BPs, thereby biasing
the bipotential progenitors cells toward a HC fate rather than a SC fate. And yet a
significant decrease in the ratio of GFP+ SCs/GFP+ HCs was only observed at the middle
region of the BP. This was difficult to interpret either by the progression of cell cycle
withdrawal from base to apex (Katayama et al., 1989) or by the differentiation gradient
from apex to base (Cotanche et al., 1983).
One possible mechanism for the decrease in SC/HC ratio was a perturbation in
Notch-mediated lateral inhibition by misexpression of the miR-183 family, thus HC
number increased at the expense of SCs. Hes1 is one downstream target of Notch
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signaling and mammalian Hes1 is predicted to have a miR-96/182 binding site. However,
the binding site is not found in chicken Hes1 3’UTR. An alternative mechanism could be
that the miR-183 family might suppress some SC genes or indirectly activate HC genes,
thereby promoting a HC fate. Sox2 is a good candidate as a downstream effector, as it is
first broadly expressed in progenitor cells and then become restricted to SCs (Neves et al.,
2007) and its misexpression could repress the development of HCs (Dabdoub et al.,
2008). Despite that mouse Sox2 was validated as a target of miR-182 (Weston et al.,
2011), I did not see a qualitative reduction in Sox2 level in the GFP+ SCs in the pGFP183F-transfected BPs using immunofluorescence.
6.2.6

Validated targets of the miR-183 family

In addition to playing a role in the development and maintenance of sensory cells,
the miR-183 family is misregulated in certain tumor tissues and cancer cell lines (Wei et
al., 2015; Zhang et al., 2013b), in which a number of gene targets have been identified
(Table 6-2).
Two of the validated targets, MITF (Segura et al., 2009; Xu et al., 2007; Yan et al.,
2012) and RASA1 (Figure 5-1), were also expressed in the BP with a base-to-apex
gradient (Frucht et al., 2011). The binding site for miR-96/182 in human MITF and the
two binding sites for miR-182 in human RASA1 are conserved in the chicken genes,
respectively. MITF is recognized as a deafness gene underlying melanocyte loss in stria
vascularis and absent endocochlear potential in Waardenburg syndrome type 2A (Steel et
al., 1989; Yajima et al., 1999). Furthermore, a more recent study reported OHC loss in
heterozygous Microphthalmia-White (MitfMi-wh/+) mice at P28 with more severe loss at
the base (Ni et al., 2013), although the mechanism of its function in HCs is largely
unknown.
COL2A1 is another deafness gene in the list of validated targets of miR-96 (Mencía
et al., 2009). Mutations in COL2A1 underlie type I Stickler syndrome and about half
patients with the syndrome exhibit hearing impairment, mainly sensorineural hearing loss
(Acke et al., 2012). COL2A1 is expressed in the outermost extent of the otic capsule at
E13.5 and in the SE as well as the outer capsule in the cochlea at E17.5 (Ficker et al.,
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2004). CACNB4, one miR-96 target, encodes voltage-activated Ca2+ channel β 4 subunit
expressed in the cochlear HCs. In the mutant mice (Cavβ4Ih/Ih), neonatal IHCs had smaller
membrane capacitances and mature IHCs had reduced Ba2+ peak currents (Kuhn et al.,
2009). MYRIP is another validated miR-96 target and it is expressed in the HCs in the
synaptic region and along the HC bundles (El-Amraoui et al., 2002). MYRIP and GTPase
Rab27 interact with myosin-VIIa to link secretary granules to F-actin and regulate their
movement toward the release sites (Desnos et al., 2003). ODF2 has faint expression in
HCs and strong expression in the neural dendrites innervating the HCs, especially the
portions directly underneath HCs (Carlisle et al., 2012).
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Table 6-2 Validated targets of the miR-183 family based on bioactivity assays
Target genes
(model organisms)
miR-183

Experimental approach

EGR1 (h, r)

Luciferase assay; mRNA level

IRS1 (r)
ITGB1 (h) %
KIF2A (h) %
PDCD4 (h) %

mRNA level
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay; GFP assay;
protein and mRNA level
mRNA level

SLC1A1 (m)
TAOK1 (r) %

References
(Patel et al., 2013; Sarver et al.,
2010)
(Patel et al., 2013)
(Li et al., 2010a)
(Li et al., 2010a)
(Li et al., 2010c)
(Krol et al., 2010)
(Patel et al., 2013)

BOLD font indicates genes expressed in cochlear HCs (GFP+) at greater than 50 reads at
P0, P4 and/or P7 in Pou4f3-GFP mice. Italics font indicates genes repressed at least 30%
in P0 cochlear HCs (GFP+) vs. other cochlear cells (GFP-) in Pou4f3-GFP mice (the
repression ratio was only checked for genes in bold font; Shared Harvard Inner-Ear
Laboratory Database: https://shield.hms.harvard.edu/index.html).
Abbreviations: h, human; m, mouse; r: rat.
* Tested as a potential target for hsa-miR-96(13G>A), but also repressed by wildtype
hsa-miR-96.
** Tested as a potential target for hsa-miR-96(14C>A), but also repressed by wildtype
hsa-miR-96.
$ The miR-96 binding site is present in the coding region, not in the 3'UTR.
# These may not be valid targets because they were repressed less than 30% in the
presence of the miRNA.
% The chicken gene is also a predicted target of gga-miR-183, gga-miR-96 or gga-miR182.
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Table 6-2 Continued
Target genes
(model organisms)
miR-96
ACVR2B (h)

Experimental approach

References

Luciferase assay

ADCY6 (h)

Luciferase assay; protein level

AQP5 (m, h)
ARRDC3 (m) %
AVIL (m) #
CACNB4 (h) %
CASP2 (m)
CELSR2 (m, h)
CLIC5 (m)
COL2A1 (h) *
FMNL2 (h) **
FN1 (h) %

Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Protein level

FOXO1 (h) %

Luciferase assay; protein level

FOXO3 (h) %
GPC3 (h)
HTR1B (h)
KRAS (h) %
LMX1A (h) **
MITF (h) %
MYLK (h) **
MYO1B (h) *

Luciferase assay
Protein level
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay

MYRIP (m, h)

Luciferase assay

NEUROD4 (m)
NR3C1 (m)
ODF2 (m, h)
PGR (h, rhesus,
not m)
RAD51 (h) $
REV1 (h) %
RYK (m, h)

Luciferase assay
Luciferase assay
Luciferase assay

(Soldà et al., 2012)
(Jalvy-Delvaille et al., 2012; Xu et al.,
2007)
(Lewis et al., 2009; Mencía et al., 2009)
(Zhu et al., 2011)
(Lewis et al., 2009)
(Soldà et al., 2012)
(Zhu et al., 2011)
(Lewis et al., 2009; Mencía et al., 2009)
(Gu et al., 2013)
(Mencía et al., 2009)
(Mencía et al., 2009)
(Jalvy-Delvaille et al., 2012)
(Guttilla et al., 2009; Jalvy-Delvaille et
al., 2012)
(Lin et al., 2010)
(Jalvy-Delvaille et al., 2012)
(Jensen et al., 2010; Jensen et al., 2009)
(Yu et al., 2010)
(Mencía et al., 2009)
(Xu et al., 2007)
(Mencía et al., 2009)
(Mencía et al., 2009)
(Lewis et al., 2009; Mencía et al., 2009;
Soldà et al., 2012)
(Zhu et al., 2011)
(Riester et al., 2012)
(Lewis et al., 2009; Mencía et al., 2009)

Luciferase assay

(Liu et al., 2012a)

Luciferase assay
Luciferase assay
Luciferase assay

(Wang et al., 2012c)
(Wang et al., 2012c)
(Lewis et al., 2009; Mencía et al., 2009)
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Table 6-2 Continued
Target genes
(model organisms)
miR-96
SEMA6D (h) * #
SLC1A1 (m)
SLC19A2 (h) **
SLC39A1 (h)
SLC39A3 (h)
SLC39A7 (h)
SPAST (h) %
ZIC1 (h) *

Experimental approach

References

Luciferase assay
Luciferase assay; GFP assay; protein and
mRNA level
Luciferase assay
mRNA level
mRNA level
mRNA level
Protein level
Luciferase assay

(Mencía et al., 2009)
(Krol et al., 2010)
(Mencía et al., 2009)
(Mihelich et al., 2011)
(Mihelich et al., 2011)
(Mihelich et al., 2011)
(Henson et al., 2012)
(Mencía et al., 2009)
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Table 6-2 Continued
Target genes
(model organisms)
miR-182
ACTR2 (h) %

Experimental approach

References

Luciferase assay

Figure 5-1
(Jalvy-Delvaille et al., 2012; Xu et al.,
2007)
(Zhu et al., 2011)
(Yan et al., 2012)
(Moskwa et al., 2011)
(Zhu et al., 2011)
(Yan et al., 2012)
(Gu et al., 2013)
(Saus et al., 2010)
Figure 5-1
Figure 5-1
Figure 5-1
(Guttilla et al., 2009); not a target in
(Jalvy-Delvaille et al., 2012)
(Segura et al., 2009)
Figure 5-1
(Segura et al., 2009; Xu et al., 2007;
Yan et al., 2012)
(Wang et al., 2012a)
Figure 5-1
Figure 5-1
Figure 5-1
Figure 5-1
Figure 5-1
Figure 5-1
(Sun et al., 2010); Figure 5-1
Figure 5-1

ADCY6 (h)

Luciferase assay; protein level

ARRDC3 (m) %
BCL2 (h) %
BRCA1 (h)
CASP2 (m)
CCND2 (h)
CLIC5 (m)
CLOCK (h)
CREB3L1 (h)
EPAS1 (h) %
FOXF2 (h) %

Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay

FOXO1 (h) %

Luciferase assay; protein level

FOXO3 (h) %
MET (h)

Luciferase assay
Luciferase assay

MITF (h) %

Luciferase assay

MTSS1 (h) %
MYO1C (h)
MYRIP (h)
NCALD (h) %
PCDH8 (h) %
RAB3GAP2 (h)
RASA1 (h) %
RGS17 (h) %
RNF212 (h)

Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay
Luciferase assay; GFP assay;
protein and mRNA level
mRNA level
mRNA level
Luciferase assay
mRNA level
mRNA level
Luciferase assay
Protein level
Luciferase assay

SLC1A1 (m)
SLC30A1 (h) %
SLC30A7 (h)
SLC35A5 (h)
SLC39A1 (h)
SLC39A7 (h)
SOX2 (h) #
SPAST (h) %
TBX1 (m)

(Krol et al., 2010)
(Mihelich et al., 2011)
(Mihelich et al., 2011)
Figure 5-1
(Mihelich et al., 2011)
(Mihelich et al., 2011)
(Weston et al., 2011)
(Henson et al., 2012)
(Wang et al., 2012b)
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Appendix A

Expression of miR-9 in the basilar papilla

I assisted Michelle L. Stoller in her studies exploring the role of miR-9 in inner ear
development. This miRNA is present in mouse inner ear at P0 and P37 by quantitative
PCR and northern blot analysis (Weston et al., 2006). miR-9 is broadly expressed in
neuronal precursors and weakly present in some postmitotic neurons in the rodent brains
(Krichevsky et al., 2003; Sempere et al., 2004). miR-9 promotes neurogenesis by
inhibiting different suppressors of neuronal differentiation in zebrafish and mouse brains
(Gao, 2010). Hes1, a Notch signaling effector, is one of the targets of miR-9 in neural
progenitors (Bonev et al., 2012), which is also known to suppress HC differentiation in
inner ear (Zheng et al., 2000b; Zine et al., 2001). Interestingly, miR-9 is upregulated in
adult brain neurons treated with alcohol (Pietrzykowski et al., 2008). The splice variants
of BK channel alpha subunits have three different 3’UTRs, only one of which has a miR9 recognition element. Destabilization of the miR-9-targeted BK mRNA splice variant
leads to a change in BK channel isoforms and the development of alcohol tolerance
(Pietrzykowski et al., 2008) The gating kinetics of BK channels are the major
determinant of the characteristics frequency of HCs. Thus it is possible that miR-9 may
be involved in modulating the kinetics of BK channels in HCs.
Whole-mount in situ hybridization of the BPs using hsa-miR-9 LNA (Exiqon
18198-05, 48°C) showed that miR-9 was expressed throughout the BP at S31, but
became restricted to the abneural half of the BP with higher expression at the apex at S38
(Figure A-1). Both surface view and section view of in situ hybridization showed that
miR-9 was not expressed in HCs but was specifically expressed in the abneural SCs
(Figure A-2, A-3). The level of miR-9 in the BPs decreased from S38 to S43 (Figure A-2).
The expression of miR-9 throughout the BP at S31 and its downregulation at later
stages suggest that miR-9 might play a role in promoting the differentiation of prosensory
precursors into HCs or SCs, likewise in the brain. Further experiments need to be done to
figure out whether miR-9 is expressed in proliferating progenitors before S31 or
expressed in HCs between S31 and S38.
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Figure A-1 Expression of miR-9 at S31 and S38
miR-9 was expressed throughout the BP (outlined) at S31, whereas it was only expressed
in the abneural half of the BP at S38. Scale bar in A equals 100 µm and in B equals 500
µm.
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Figure A-2 Expression of miR-9 in the basilar papillae at S38-S43
A-D: whole-mount BPs shown with low magnification. E-L: images at the apex
(arrowheads in A-D) shown with high magnification. E-H: images taken at the HC layer.
I-L: images taken at the SC layer. The level of miR-9 decreased from S38 to S43. It was
only present in the abneural half of the BPs, with higher level at the apex. It was not
expressed in HCs, but was expressed in SCs. Scale bar in A equals 500 µm and in E
equals 20 µm.

125

Figure A-3 Expression of miR-9 in supporting cells
Section across the BP after whole mount in situ hybridization confirmed that miR-9 was
absent in the HCs and was only expressed in SCs on the abneural side. Scale bar equals
20 µm.
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Appendix B

RCAS-miR9 infection

Michelle L. Stoller inserted the miR-9 sequence as an intron flanked by splice donor
and splice acceptor sites into RCAS (replication-competent avian sarcoma-leukosis virus
long terminal repeat with a splice acceptor) to create RCAS-miR9 (9x108 3C2 infectious
units/mL). RCAS has endogenous one splice donor and two splice acceptor sites.
Therefore, RCAS-miR9 has two splicer donor sites and three splicer acceptor sites.
I injected the virus into the right otocyst of the chicken embryos at E3 and sacrificed
the embryos at E14-17. In situ hybridization of the BPs (n=6, KDZ204 E17 and KDZ218
E14) revealed that there was no ectopic miR-9 expression in the right infected BPs
(Figure B-1). It suggested that ectopic miR-9 was not produced in the chicken inner ear
after RCAS-miR9 infection, probably due to the introduction of the new splicer donor
and splicer acceptor sites.
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Figure B-1 Expression of miR-9 after RCAS-miR9 infection
RCAS-miR9 was injected into the right ears of the embryos at E3 and the embryos were
sacrificed at E17. There was no ectopic miR-9 expression in the right BPs compared with
the left BPs.
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Appendix C

RCAS-sdmut-183F-Atoh1-HA infection

Michelle L. Stoller designed an RCASBP(A)-sdmut-183F-Atoh1-HA virus (7x108
3C2 infectious units/mL, 5x106 HA11 infectious units/mL) to deliver the miR-183 family
and Aoth1 into chicken inner ear. However, she found that HA staining was really low
relative to AMV-3C2 staining (against avian myoblastosis virus) 4 days after injection of
the virus into the chicken otocyst at E3, suggesting inefficient Atoh1-HA production in
vivo. I then tested whether the virus could produce ectopic miRNAs in the inner ear. No
ectopic expression of miR-96 (n=7, KDZ200 E17/E18) and miR-182 (n=4, KDZ217 E14)
were observed (Figure C-1), suggesting that removal of the second splice donor site in
RCASBP(A)-sdmut-183F-Atoh1-HA did not promote the production of the miRNAs.
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Figure C-1 Expression of miR-96 after RCAS-sdmut-183F-Atoh1-HA infection
RCAS-sdmut-183F-Atoh1-HA was injected into the right otocyst at E3 and the embryos
were sacrificed at E17/18. The expression of miR-96 in the right BPs was comparable to
the control left BPs with no ectopic expression.
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